Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	CEBPB CENPB KLF14 FOXA1 AHDC1 CIC SVEP1 PWWP2A EHMT2 ZC3H4 KMT2A CHD6 TAF5 TAF10 TAL1 BAHCC1 SAMD1 DDX17 CBFA2T3 SKI RING1 TRIM33 NCOR1 CBX6 PKN1 VCX	3.65e-08	739	203	26	GO:0003682
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	BHLHE41 MYCN ZNF142 CEBPB KLF14 FOXA1 CIC CASZ1 ZNF771 JUND ZSCAN1 WIZ EHMT2 FUBP1 ZNF324 INSM2 BARX1 TAL1 TBX6 TBX4 ZSCAN5A ZNF316 PBX4 TEAD1 SKI TFE3 NCOR1 KLF1 NACC2 KLF13 ANHX ZSCAN18 ZFHX2 NKX1-1 ZNF853 LYL1	5.91e-07	1459	203	36	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	BHLHE41 MYCN ZNF142 CEBPB KLF14 FOXA1 CIC CASZ1 ZNF771 JUND ZSCAN1 WIZ ZNF324 INSM2 BARX1 TAL1 TBX6 TBX4 ZSCAN5A ZNF316 JPH2 PBX4 TEAD1 SKI TFE3 KLF1 NACC2 KLF13 ANHX ZSCAN18 ZFHX2 NKX1-1 ZNF853 LYL1	2.21e-06	1412	203	34	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	BHLHE41 MYCN CEBPB KLF14 FOXA1 ZNF771 JUND ZSCAN1 WIZ FUBP1 ZNF324 INSM2 TAL1 TBX6 TBX4 ZSCAN5A ZNF316 PBX4 TEAD1 SKI TFE3 KLF1 NACC2 KLF13 ANHX ZSCAN18 ZFHX2 NKX1-1 ZNF853 LYL1	9.21e-06	1244	203	30	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	BHLHE41 MYCN CEBPB KLF14 FOXA1 ZNF771 JUND ZSCAN1 WIZ FUBP1 ZNF324 INSM2 TAL1 TBX6 TBX4 ZSCAN5A ZNF316 PBX4 TEAD1 SKI TFE3 KLF1 NACC2 KLF13 ANHX ZSCAN18 ZFHX2 NKX1-1 ZNF853 LYL1	1.39e-05	1271	203	30	GO:0000987
GeneOntologyMolecularFunction	transcription factor binding	BHLHE41 CEBPB KLF14 FOXA1 JUND WIZ EHMT2 KMT2A CHD6 TAF4 BSN TAF10 TAL1 TBX6 TACC2 SKI NCOR1 KLF1 CHCHD2 PKN1	8.90e-05	753	203	20	GO:0008134
GeneOntologyMolecularFunction	kinase binding	MYCN CEBPB WNK1 STK11IP SHC3 ADD2 MAPK8IP3 PKD1 SYN1 KCNQ1 STK39 PLK1 CDK5R2 KIF13B GOLGA8K GRIN2A SKI PITPNM1 GOLGA8B PKN1 MAPK7 GOLGA8A MARCKS	1.41e-04	969	203	23	GO:0019900
GeneOntologyMolecularFunction	potassium channel inhibitor activity	WNK1 WNK2 NEDD4L	1.61e-04	11	203	3	GO:0019870
GeneOntologyMolecularFunction	protein kinase binding	WNK1 STK11IP SHC3 ADD2 MAPK8IP3 PKD1 SYN1 KCNQ1 STK39 PLK1 CDK5R2 KIF13B GOLGA8K GRIN2A SKI PITPNM1 GOLGA8B PKN1 MAPK7 GOLGA8A MARCKS	2.33e-04	873	203	21	GO:0019901
GeneOntologyMolecularFunction	cytoskeletal protein binding	MAP1A SPIRE1 ADD2 MAPK8IP3 AP1G1 SYN1 GNAS PLK1 CDK5R2 FMNL1 KIF13B RPH3AL COBLL1 GOLGA8K MIB2 TUBGCP6 GAS2L1 GOLGA8B MACF1 CROCC GOLGA8A MARCKS MYBPC3	8.27e-04	1099	203	23	GO:0008092
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	BHLHE41 CEBPB FOXA1 JUND KMT2A TAF4 TAF10 TAL1 TBX6 TACC2 SKI NCOR1 KLF1 CHCHD2 PKN1	9.35e-04	582	203	15	GO:0140297
GeneOntologyMolecularFunction	importin-alpha family protein binding	GOLGA8K GOLGA8B GOLGA8A	1.20e-03	21	203	3	GO:0061676
GeneOntologyMolecularFunction	microtubule binding	MAP1A SPIRE1 PLK1 KIF13B GOLGA8K TUBGCP6 GAS2L1 GOLGA8B MACF1 GOLGA8A	1.26e-03	308	203	10	GO:0008017
GeneOntologyMolecularFunction	actin binding	MAP1A SPIRE1 ADD2 SYN1 CDK5R2 FMNL1 COBLL1 MIB2 GAS2L1 MACF1 CROCC MARCKS MYBPC3	1.29e-03	479	203	13	GO:0003779
GeneOntologyMolecularFunction	molecular adaptor activity	BHLHE41 MAP1A ANKRD9 BECN2 SUPT20HL2 ZZEF1 WNK1 TRRAP AHDC1 MAPK8IP3 JUND AP1G1 BASP1 SYN1 INSM2 DDX17 TCOF1 NIBAN2 DZIP1 CBFA2T3 SKI GAS2L1 NCOR1 PKN1 EIF3B HERPUD1	1.35e-03	1356	203	26	GO:0060090
GeneOntologyCellularComponent	chromatin	BHLHE41 MYCN CEBPB ARID4B CENPB KLF14 SUPT20HL2 FOXA1 TRRAP CIC CASZ1 JUND ZSCAN1 EHMT2 BASP1 CHD6 TAF4 TAF5 TAF10 BARX1 PLK1 TAL1 TBX6 TBX4 PBX4 TEAD1 TFE3 RING1 TRIM33 NCOR1 KLF1 NACC2 KLF13 CBX6 ZFHX2 NKX1-1 LYL1	1.38e-07	1480	206	37	GO:0000785
GeneOntologyCellularComponent	Golgi cis cisterna	GOLGA8S GOLGA8R GOLGA8K GOLGA8DP GOLGA8B GOLGA8A	7.55e-07	33	206	6	GO:0000137
GeneOntologyCellularComponent	transcription factor TFTC complex	TRRAP TAF4 TAF5 TAF10	2.52e-05	18	206	4	GO:0033276
GeneOntologyCellularComponent	SAGA-type complex	SUPT20HL2 TRRAP TAF4 TAF5 TAF10	3.88e-05	39	206	5	GO:0070461
GeneOntologyCellularComponent	Golgi cisterna membrane	GOLGA8S GOLGA8R GOLGA8K PITPNM1 GOLGA8DP GOLGA8B GOLGA8A	4.04e-05	94	206	7	GO:0032580
GeneOntologyCellularComponent	cis-Golgi network	GOLGA8S GOLGA8R GOLGA8K GOLGA8DP GOLGA8B GOLGA8A	1.95e-04	85	206	6	GO:0005801
GeneOntologyCellularComponent	Golgi cisterna	GOLGA8S GOLGA8R GOLGA8K PITPNM1 GOLGA8DP GOLGA8B GOLGA8A	3.89e-04	135	206	7	GO:0031985
GeneOntologyCellularComponent	PRC1 complex	PCGF6 RING1 CBX6	8.13e-04	19	206	3	GO:0035102
GeneOntologyCellularComponent	transcription regulator complex	BHLHE41 CEBPB TRRAP JUND INSM2 TAF4 TAF5 TAF10 TAL1 TEAD1 SKI TFE3 NCOR1 GTF3C1 ANHX	8.73e-04	596	206	15	GO:0005667
MousePheno	abnormal cervical atlas morphology	PCGF6 KMT2A TBX6 SKI RING1 CHRD	2.96e-05	51	166	6	MP:0004607
MousePheno	skin edema	CASZ1 SVEP1 PKD1 KMT2A GNAS TAL1	3.71e-05	53	166	6	MP:0001786
MousePheno	pale yolk sac	MYCN WNK1 TAL1 SAMD1 TBX4 UBR4 TEAD1 MAPK7	4.90e-05	110	166	8	MP:0001722
Domain	VCX_VCY	VCX3B VCX2 VCX3A VCX	6.46e-08	5	201	4	PF15231
Domain	VCX/VCY1	VCX3B VCX2 VCX3A VCX	6.46e-08	5	201	4	IPR026653
Domain	OSR1_C	WNK1 STK39 WNK2	2.40e-05	6	201	3	PF12202
Domain	Kinase_OSR1/WNK_CCT	WNK1 STK39 WNK2	2.40e-05	6	201	3	IPR024678
Domain	Cysteine_dSase	SCLY NFS1	1.15e-04	2	201	2	IPR016454
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 CEBPB ANKRD9 SPEG C15orf39 SPIRE1 PIGG ZZEF1 WNK1 STK11IP TRRAP AHDC1 RNF43 CIC CASZ1 MAPK8IP3 SCAF1 JUND WIZ IER5L TMEM259 PKD1 WNK2 BAHCC1 MEX3D UBR4 ZNF316 FBRS FBRSL1 TBC1D25 MIB2 TFE3 KCNH3 UNC119 GAS2L1 NCOR1 ARHGEF40 AATK PALM PKN1 DHX34	9.74e-21	1105	211	41	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PSD ARID4B MAP1A CENPB FOXA1 ZZEF1 TRRAP RNF43 ZNF771 SCAF1 WIZ EHMT2 ZC3H4 ZNF324 STK39 TAF4 TAF5 TAF10 BAHCC1 SAMD1 TCOF1 ZNF316 FBRS FBRSL1 SIK3 SKI KIAA1671 TUBGCP6 TRIM33 TBC1D10B ARHGEF40 MACF1 DHX34	5.62e-14	1116	211	33	31753913
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MYCN ATXN2L ARID4B RRBP1 TRRAP CIC MAPK8IP3 SCAF1 JUND USP42 ZC3H4 FUBP1 KMT2A TCOF1 SAMD4B BAG3 NIBAN2 PITPNM1 TUBGCP6 NCOR1 TBC1D10B GTF3C1 PKN1 EIF3B OGA	1.27e-11	774	211	25	15302935
Pubmed	Human transcription factor protein interaction networks.	ARID4B C15orf39 FOXA1 TRRAP CIC ZNF771 PCGF6 JUND WIZ EHMT2 BASP1 FUBP1 KMT2A CHD6 TAF4 TAF5 TAF10 TAL1 UBR4 FBRS FBRSL1 TEAD1 GTPBP1 SKI TFE3 RING1 KIAA1671 TRIM33 NCOR1 UBE2O GTF3C1 ZSCAN18 EIF3B	4.38e-11	1429	211	33	35140242
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ATXN2L MAP1A ADD2 MAPK8IP3 RUSC2 AMER2 BASP1 AJM1 SYN1 BSN NEDD4L GRIN2A GTPBP1 PITPNM1 PALM MACF1 MARCKS	5.34e-11	347	211	17	17114649
Pubmed	Interaction network of human early embryonic transcription factors.	ARID4B C15orf39 AHDC1 PCGF6 WIZ EHMT2 KMT2A TAF4 BAHCC1 FBRS FBRSL1 TEAD1 SKI RING1 KIAA1671 TRIM33 NCOR1	6.38e-11	351	211	17	38297188
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CEBPB ARID4B RPLP1 RRBP1 TRRAP AHDC1 CIC CASZ1 PWWP2A SCAF1 PCGF6 JUND WIZ USP42 EHMT2 KMT2A CHD6 TAF4 TAF5 TAF10 SAMD1 DDX17 TCOF1 ZSCAN5A TEAD1 SKI TFE3 RING1 NCOR1 GTF3C1 KLF13	7.41e-11	1294	211	31	30804502
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAPK8IP3 WIZ EHMT2 TMEM259 BASP1 ZC3H4 SYN1 TAF4 TAF5 BSN WNK2 KIF13B NEDD4L TCOF1 PRR36 UBR4 GOLGA8K GRIN2A SIK3 NCOR1 UBE2O ZSCAN18 GOLGA8B MACF1 PKN1 GOLGA8A	2.36e-10	963	211	26	28671696
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ATXN2L RPLP1 RRBP1 WNK1 EHMT2 ZC3H4 FUBP1 STK39 DDX17 TCOF1 COBLL1 SAMD4B GPS1 BAG3 TACC2 NIBAN2 NCOR1 GTF3C1 PKN1	3.17e-10	503	211	19	16964243
Pubmed	A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation.	VCX3B VCX2 VCX3A VCX	1.32e-09	4	211	4	10903929
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MYCN CEBPB ARID4B CENPB RRBP1 FOXA1 TRRAP CIC CASZ1 LACTB PCGF6 JUND WIZ TAF10 BARX1 SAMD1 UBR4 CBFA2T3 SKI TRIM33 NCOR1 GTF3C1 NACC2	3.10e-09	857	211	23	25609649
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SPIRE1 RRBP1 ZZEF1 SYNJ2 ZC3H4 BSN ARHGAP20 WNK2 RALGDS FBRSL1 DZIP1 SIK3 TUBGCP6 TRIM33 UBE2O PALM OGA DHX34	4.86e-09	529	211	18	14621295
Pubmed	A human sex-chromosomal gene family expressed in male germ cells and encoding variably charged proteins.	VCX2 VCX3A VCY VCX	6.55e-09	5	211	4	10607842
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP1A SPEG ADD2 MAPK8IP3 AMER2 AJM1 FUBP1 SYN1 BSN GRIN2A MACF1 EIF3B	2.05e-08	231	211	12	16452087
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ATXN2L TRRAP WIZ ZC3H4 FUBP1 KMT2A PLK1 KIF13B SAMD1 TCOF1 UBR4 NFS1 NCOR1 GTF3C1	2.62e-08	341	211	14	32971831
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	ARMCX2 AHDC1 ADD2 MAPK8IP3 PWWP2A AFAP1L2 IER5L EHMT2 BASP1 ZC3H4 FUBP1 PKD1 GNAS COL5A1 DUSP7 ZNF316 TACC2 NIBAN2 IRGQ TEAD1 TUBGCP6 TRIM33 CHCHD2 PALM DHX34 MARCKS	2.85e-08	1215	211	26	15146197
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ARID4B TRRAP CIC CASZ1 PWWP2A PCGF6 WIZ EHMT2 KMT2A CHD6 TAF4 SAMD1 CENPT TEAD1 RING1 UBE2O GTF3C1 ZSCAN18	4.07e-08	608	211	18	36089195
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MYCN POLR2M CIC LACTB AFAP1L2 USP42 TAF4 TAF10 SAMD1 ZSCAN5A SAMD4B UBR4 DUSP7 GPS1 ZNF316 SIK3 TRIM33 NCOR1 UBE2O	5.14e-08	689	211	19	36543142
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATXN2L RPLP1 MAP1A SPIRE1 RRBP1 ADD2 LACTB MAPK8IP3 AP1G1 AJM1 SYN1 KMT2A BSN WNK2 DDX17 CARMIL2 NEDD4L PRR36 GRIN2A GTPBP1 PITPNM1 GAS2L1 UBE2O CRACDL KNDC1 PALM MACF1 CROCC	5.25e-08	1431	211	28	37142655
Pubmed	A human MAP kinase interactome.	ZNF142 ARID4B MAP1A WNK1 CIC SYNJ2 CHD6 WNK2 RALGDS NEDD4L COBLL1 BAG3 SIK3 MACF1 MAPK7 HERPUD1	5.63e-08	486	211	16	20936779
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	AHDC1 PWWP2A PCGF6 WIZ EHMT2 KMT2A SAMD1 ZSCAN5A ZNF316 FBRS FBRSL1 RING1 UBE2O CBX6 EIF3B OGA	7.23e-08	495	211	16	27705803
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ATXN2L SPIRE1 WNK1 CIC RUSC2 SYNJ2 KMT2A GNAS PLK1 KIF13B CARMIL2 NEDD4L COBLL1 SAMD4B BAG3 DZIP1 SIK3 KIAA1671 UNC119 TBC1D10B MACF1	7.89e-08	861	211	21	36931259
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	FOXA1 AHDC1 CIC CASZ1 WIZ EHMT2 ZC3H4 KMT2A FBRS SKI TRIM33 NCOR1	1.04e-07	268	211	12	33640491
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	C15orf39 RRBP1 ZZEF1 RUSC2 AP1G1 ZC3H4 KMT2A RALGDS SAMD4B FBRSL1 MIB2 SIK3 GTPBP1 RGS3 TBC1D10B ARHGEF40 GTF3C1 DHX34	1.10e-07	650	211	18	38777146
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SPIRE1 RRBP1 TRRAP AHDC1 CASZ1 MAPK8IP3 SYNJ2 FUBP1 CHD6 TAF4 GNAS WNK2 COL5A1 RPH3AL NEDD4L SAMD4B FBRSL1 SKI KIAA1671 GTF3C1 NACC2 GPR137C KNDC1 ZFHX2 MACF1 PKN1 CROCC PDZD2	1.19e-07	1489	211	28	28611215
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	BHLHE41 CEBPB ARID4B CIC PCGF6 WIZ EHMT2 TAF4 TAF5 PLK1 DDX17 TEAD1 GTPBP1 SKI RING1 GTF3C1 EIF3B	1.22e-07	583	211	17	29844126
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ATXN2L MAP1A TSPOAP1 RRBP1 MAPK8IP3 AMER2 BASP1 AJM1 BSN WNK2 DDX17 NEDD4L UBR4 TACC2 MIB2 GRIN2A NFS1 PITPNM1 UBE2O KNDC1 PALM MACF1 EIF3B MARCKS	1.35e-07	1139	211	24	36417873
Pubmed	Functional proteomics mapping of a human signaling pathway.	RRBP1 ZZEF1 SVEP1 AP1G1 UBAC1 PKD1 CHD6 FMNL1 TBX4 NEDD4L UBR4 NIBAN2 BTBD2 SKI RGS3 NCOR1 MACF1	1.48e-07	591	211	17	15231748
Pubmed	Analysis of the VCX3A, VCX2 and VCX3B genes shows that VCX3A gene deletion is not sufficient to result in mental retardation in X-linked ichthyosis.	VCX3B VCX2 VCX3A	2.20e-07	3	211	3	18076704
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	C15orf39 POLR2M WNK1 RUSC2 AP1G1 TBC1D12 ARHGAP29 GNAS DDX17 NEDD4L TCOF1 MEX3D SAMD4B DUSP7 FBRS FBRSL1 FRAT2 TFE3 RING1 TRIM33 KNDC1 MAPK7	4.21e-07	1038	211	22	26673895
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CEBPB SPIRE1 PIGG TRRAP AHDC1 CIC CASZ1 PWWP2A SCAF1 WIZ AP1G1 EHMT2 KMT2A CHD6 TAF4 TAF5 TAF10 SAMD1 TENT4B SAMD4B KIAA1671 TRIM33 CRACDL MACF1 EIF3B CROCC MARCKS	4.63e-07	1497	211	27	31527615
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	MYCN CENPB FOXA1 CIC PCGF6 JUND ZSCAN1 EHMT2 INSM2 TAF5 BARX1 TAL1 TBX4 PBX4 TEAD1 SKI GTF3C1 KLF13 CBX6 ZSCAN18	4.71e-07	877	211	20	20211142
Pubmed	The human SPT20-containing SAGA complex plays a direct role in the regulation of endoplasmic reticulum stress-induced genes.	SUPT20HL2 TRRAP TAF4 TAF5 TAF10	6.88e-07	28	211	5	19114550
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L MAP1A C15orf39 WNK1 CIC GNAS BSN KIF13B TCOF1 FBRS FBRSL1 TACC2 KIAA1671 TRIM33 NCOR1 MACF1	7.22e-07	588	211	16	38580884
Pubmed	A census of human transcription factors: function, expression and evolution.	BHLHE41 MYCN CEBPB FOXA1 CIC JUND KMT2A BARX1 TAL1 TBX6 TBX4 CENPT PBX4 TEAD1 SKI TFE3 KLF1 KLF13 ZFHX2 LYL1	8.06e-07	908	211	20	19274049
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	RRBP1 TRRAP PCGF6 ZC3H4 KMT2A TAF10 PLK1 FBRS FBRSL1 SIK3 NFS1 PRX RING1 UNC119 ARHGEF40 GTF3C1 PKN1 EIF3B MAPK7 MARCKS	8.34e-07	910	211	20	36736316
Pubmed	Pathogenicity of lupus anti-ribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model.	ZZEF1 BSN GRIN2A	8.77e-07	4	211	3	25709106
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	TRRAP AHDC1 PCGF6 CHD6 TAF4 TAF5 TAF10 RING1	9.68e-07	124	211	8	20850016
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	TRRAP TAL1 CBFA2T3 NCOR1 LYL1	9.87e-07	30	211	5	26593974
Pubmed	A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing.	SUPT20HL2 TRRAP TAF4 TAF5 TAF10	9.87e-07	30	211	5	18206972
Pubmed	Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo.	SUPT20HL2 TRRAP TAF4 TAF5 TAF10	1.62e-06	33	211	5	11564863
Pubmed	Novel subunits of the TATA binding protein free TAFII-containing transcription complex identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry following one-dimensional gel electrophoresis.	TRRAP TAF4 TAF5 TAF10	1.71e-06	15	211	4	12601814
Pubmed	RhoA-mediated FMNL1 regulates GM130 for actin assembly and phosphorylates MAPK for spindle formation in mouse oocyte meiosis.	FMNL1 GOLGA8K GOLGA8B GOLGA8A	1.71e-06	15	211	4	26083584
Pubmed	The architecture of human general transcription factor TFIID core complex.	TAF4 TAF5 TAF10	2.18e-06	5	211	3	23292512
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	C15orf39 RRBP1 CIC WIZ KMT2A TAF4 DDX17 BAG3 FBRS TFE3 TRIM33 NCOR1 MARCKS	2.30e-06	425	211	13	24999758
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MAP1A TSPOAP1 WNK1 CIC BSN WNK2 NEDD4L TCOF1 UBR4 PRX KIAA1671 NCOR1 AATK	2.61e-06	430	211	13	35044719
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	CIC ADD2 AMER2 SYN1 TCOF1 PALM PKN1 EIF3B OGA MARCKS	2.93e-06	246	211	10	15345747
Pubmed	Histone-like TAFs within the PCAF histone acetylase complex.	TRRAP TAF4 TAF5 TAF10	2.95e-06	17	211	4	9674425
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ZZEF1 SCAF1 AFAP1L2 WIZ BASP1 UBAC1 PKD1 CHD6 ARHGAP20 CDK5R2 UBR4 ZNF316 SLC26A9 PBX4 KIAA1671 GTF3C1 CHRD	2.98e-06	736	211	17	29676528
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	RPLP1 SPIRE1 TRRAP CIC WIZ BASP1 ZC3H4 FUBP1 TAF10 DDX17 TCOF1 COBLL1 UBE2O EIF3B	3.00e-06	506	211	14	30890647
Pubmed	TIF1gamma controls erythroid cell fate by regulating transcription elongation.	TAL1 CBFA2T3 TRIM33 LYL1	3.77e-06	18	211	4	20603019
Pubmed	A shared promoter region suggests a common ancestor for the human VCX/Y, SPANX, and CSAG gene families and the murine CYPT family.	VCX3B VCY VCX	4.34e-06	6	211	3	17342728
Pubmed	SDF2L1 interacts with the ER-associated degradation machinery and retards the degradation of mutant proinsulin in pancreatic β-cells.	GOLGA8K GOLGA8B GOLGA8A HERPUD1	4.75e-06	19	211	4	23444373
Pubmed	Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2.	NEDD4L GOLGA8K GOLGA8B GOLGA8A	4.75e-06	19	211	4	17003038
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATXN2L RPLP1 MAP1A RRBP1 WNK1 CIC WIZ ZC3H4 KMT2A DDX17 TCOF1 BAG3 TACC2 NIBAN2 KIAA1671 UBE2O MACF1 OGA MARCKS	4.84e-06	934	211	19	33916271
Pubmed	PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes.	PCGF6 FBRS FBRSL1 RING1 CBX6	4.92e-06	41	211	5	22325352
Pubmed	UV-damaged DNA-binding protein in the TFTC complex links DNA damage recognition to nucleosome acetylation.	TRRAP TAF4 TAF5 TAF10	5.91e-06	20	211	4	11406595
Pubmed	Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II.	TRRAP TAF4 TAF5 TAF10	5.91e-06	20	211	4	9603525
Pubmed	Identification of TATA-binding protein-free TAFII-containing complex subunits suggests a role in nucleosome acetylation and signal transduction.	TRRAP TAF4 TAF5 TAF10	5.91e-06	20	211	4	10373431
Pubmed	Systematic protein-protein interaction mapping for clinically relevant human GPCRs.	CENPB GPR182 PIGG SCAF1 EHMT2 TMEM259 BASP1 PKD1 GNAS PRR36 UBR4 CBFA2T3 CRLS1 AATK GOLGA8A HERPUD1	6.35e-06	697	211	16	28298427
Pubmed	Serum and glucocorticoid-induced kinase (SGK) 1 and the epithelial sodium channel are regulated by multiple with no lysine (WNK) family members.	WNK1 WNK2 NEDD4L	7.57e-06	7	211	3	20525693
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATXN2L TRRAP WIZ KMT2A TAF4 TAF5 PLK1 TCOF1 BAG3 TEAD1 KIAA1671 NCOR1 UBE2O GTF3C1	7.59e-06	549	211	14	38280479
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	TRRAP PCGF6 KMT2A TAF10 PLK1 FBRS FBRSL1 RING1 TRIM33 GTF3C1 OGA	8.07e-06	339	211	11	30415952
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ZNF142 ARID4B CIC CASZ1 CCDC85A CHD6 BSN TBX4 UBR4 FBRS FBRSL1 TBC1D25 SIK3 TFE3 NCOR1	9.40e-06	638	211	15	31182584
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	C15orf39 CIC WIZ EHMT2 CHD6 SAMD1 UBR4 BAG3 FBRS KIAA1671 NCOR1 GTF3C1	1.07e-05	418	211	12	34709266
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MAP1A TRRAP AHDC1 ADD2 WIZ USP42 ZC3H4 ZNF324 CHD6 DDX17 NEDD4L TCOF1 SIK3 CBFA2T3 TBC1D10B GTF3C1 MACF1 EIF3B TNXB MARCKS	1.10e-05	1082	211	20	38697112
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	TRRAP PCGF6 EHMT2 SAMD1 ZSCAN5A TRIM33 GTF3C1	1.19e-05	125	211	7	32891193
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	VWA5B2 C15orf39 CASZ1 SCAF1 BSN WNK2 UBR4 RGS3 NCOR1	1.39e-05	233	211	9	37704626
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF142 CIC MAPK8IP3 UBR4 NCOR1 AATK	1.56e-05	87	211	6	12465718
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	ATXN2L TRRAP AHDC1 JUND WIZ EHMT2 BASP1 ZC3H4 KMT2A COL5A1 DDX17 TENT4B TCOF1 NIBAN2 NCOR1 GTF3C1 EIF3B	1.85e-05	847	211	17	35850772
Pubmed	Disruption of Trip11 in cranial neural crest cells is associated with increased ER and Golgi stress contributing to skull defects in mice.	GOLGA8K TFE3 GOLGA8B GOLGA8A	2.07e-05	27	211	4	35147267
Pubmed	Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells.	TRRAP DDX17 NCOR1	2.56e-05	10	211	3	12738788
Pubmed	Role of beta-catenin in synaptic vesicle localization and presynaptic assembly.	SYN1 BSN GRIN2A	2.56e-05	10	211	3	14622577
Pubmed	A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells.	PCGF6 EHMT2 RING1	2.56e-05	10	211	3	12004135
Pubmed	The nuclear import of TAF10 is regulated by one of its three histone fold domain-containing interaction partners.	TRRAP TAF5 TAF10	2.56e-05	10	211	3	15870280
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	BHLHE41 MYCN CEBPB KLF14 FOXA1 ZNF771 JUND ZSCAN1 TBX6 ZSCAN5A TEAD1 TFE3 KLF13	3.16e-05	544	211	13	28473536
Pubmed	Epithelial dynamics of pancreatic branching morphogenesis.	BARX1 GOLGA8K GOLGA8B GOLGA8A	3.19e-05	30	211	4	21098570
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	CENPB FOXA1 RNF43 CIC PCGF6 JUND KMT2A TBX4 TACC2 TEAD1 TFE3 RING1 GTF3C1 ZFHX2 MACF1	3.19e-05	709	211	15	22988430
Pubmed	CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues.	TAF4 TAF5 TAF10	3.50e-05	11	211	3	9153318
Pubmed	MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2.	MYCN KMT2A RING1	3.50e-05	11	211	3	31856871
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	EHMT2 SYNJ2 PKD1 KCNQ1 TAL1 WNK2 NFS1 PRX CHRD LTBP2	3.64e-05	329	211	10	17474147
Pubmed	Association of KCNQ1 and KLF14 polymorphisms and risk of type 2 diabetes mellitus: A global meta-analysis.	KLF14 KCNQ1	3.66e-05	2	211	2	24486580
Pubmed	Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival.	TAL1 LYL1	3.66e-05	2	211	2	19200805
Pubmed	The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.	TAL1 LYL1	3.66e-05	2	211	2	17053063
Pubmed	Modulation of neuritogenesis by a protein implicated in X-linked mental retardation.	VCX3B VCX3A	3.66e-05	2	211	2	19812318
Pubmed	G9a mediates Sharp-1-dependent inhibition of skeletal muscle differentiation.	BHLHE41 EHMT2	3.66e-05	2	211	2	23087213
Pubmed	Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians.	KLF14 KCNQ1	3.66e-05	2	211	2	23630301
Pubmed	STK39 and WNK1 Are Potential Hypertension Susceptibility Genes in the BELHYPGEN Cohort.	WNK1 STK39	3.66e-05	2	211	2	27082544
Pubmed	Forkhead transcription factor Foxa1 is a novel target gene of C/EBPβ and suppresses the early phase of adipogenesis.	CEBPB FOXA1	3.66e-05	2	211	2	21167261
Pubmed	G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta.	CEBPB EHMT2	3.66e-05	2	211	2	18647749
Pubmed	Sumoylation of the basic helix-loop-helix transcription factor sharp-1 regulates recruitment of the histone methyltransferase G9a and function in myogenesis.	BHLHE41 EHMT2	3.66e-05	2	211	2	23637228
Pubmed	ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis.	TAL1 CBFA2T3	3.66e-05	2	211	2	16287841
Pubmed	Human autoantibodies to a novel Golgi protein golgin-67: high similarity with golgin-95/gm 130 autoantigen.	GOLGA8B GOLGA8A	3.66e-05	2	211	2	10677249
Pubmed	Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors.	CIC FUBP1	3.66e-05	2	211	2	24030748
Pubmed	Expression and localization of VCX/Y proteins and their possible involvement in regulation of ribosome assembly during spermatogenesis.	VCX3B VCX	3.66e-05	2	211	2	12862317
Pubmed	WNK lysine deficient protein kinase 1 regulates human endometrial stromal cell decidualization, proliferation, and migration in part through mitogen-activated protein kinase 7.	WNK1 MAPK7	3.66e-05	2	211	2	29025069
Pubmed	WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia.	WNK1 WNK2	3.66e-05	2	211	2	35849656
Pubmed	Interactions between adaptor protein-1 of the clathrin coat and microtubules via type 1a microtubule-associated proteins.	MAP1A AP1G1	3.66e-05	2	211	2	11418592
Pubmed	Stimulation of KLF14/PLK1 pathway by thrombin signaling potentiates endothelial dysfunction in Type 2 diabetes mellitus.	KLF14 PLK1	3.66e-05	2	211	2	29710485
Pubmed	Stable centrosomal roots disentangle to allow interphase centriole independence.	PLK1 CROCC	3.66e-05	2	211	2	29649211
Interaction	TOP3B interactions	VWA5B2 MYCN CEBPB ANKRD9 SPEG C15orf39 SPIRE1 PIGG ZZEF1 WNK1 STK11IP TRRAP AHDC1 RNF43 CIC CASZ1 MAPK8IP3 SCAF1 JUND WIZ IER5L TMEM259 PKD1 GNAS WNK2 BAHCC1 MEX3D SAMD4B UBR4 ZNF316 FBRS FBRSL1 TBC1D25 MIB2 GTPBP1 TFE3 KCNH3 UNC119 GAS2L1 NCOR1 ARHGEF40 AATK PALM PKN1 OGA DHX34	1.86e-12	1470	200	46	int:TOP3B
Interaction	NFIX interactions	ARID4B FOXA1 TRRAP CIC WIZ EHMT2 KMT2A TAF4 TAF5 NEDD4L SKI RING1 NCOR1 GTF3C1 MYBPC3	8.71e-09	227	200	15	int:NFIX
Interaction	FEV interactions	ARID4B C15orf39 CIC WIZ EHMT2 KMT2A CHD6 TAF4 TAF5 FBRS FBRSL1 RING1 NCOR1 GTF3C1	1.61e-08	203	200	14	int:FEV
Interaction	CBX3 interactions	MYCN CEBPB AHDC1 CIC PCGF6 WIZ EHMT2 ZC3H4 ZNF324 KMT2A TAF4 CENPT TCOF1 COBLL1 ZNF316 FBRS TFE3 RING1 TRIM33 NCOR1 UBE2O GTF3C1 CBX6 MACF1	2.93e-08	646	200	24	int:CBX3
Interaction	KLF3 interactions	ARID4B CIC PCGF6 WIZ EHMT2 KMT2A CHD6 TAF4 FBRS FBRSL1 SKI TFE3 RING1 NCOR1	6.95e-08	228	200	14	int:KLF3
Interaction	YWHAB interactions	MYCN ATXN2L CEBPB SPEG SPIRE1 FOXA1 WNK1 TRRAP RNF43 CIC RUSC2 SYNJ2 BASP1 KMT2A KIF13B CARMIL2 NEDD4L COBLL1 SAMD4B BAG3 DZIP1 SIK3 RGS3 TFE3 KIAA1671 TRIM33 TBC1D10B MACF1 MAPK7 MARCKS	8.13e-08	1014	200	30	int:YWHAB
Interaction	CSNK2A2 interactions	BHLHE41 MYCN JPH4 ARID4B RPLP1 TRRAP PCGF6 ZC3H4 ARHGAP29 KMT2A COL5A1 TCOF1 ZSCAN5A FBRS FBRSL1 GRIN2A RING1 PITPNM1 VPS9D1 UBE2O GTF3C1 KLF1 EIF3B	7.96e-07	718	200	23	int:CSNK2A2
Interaction	EGR2 interactions	ARID4B C15orf39 AHDC1 PCGF6 WIZ KMT2A BAHCC1 FBRS FBRSL1 TRIM33 NCOR1	1.16e-06	171	200	11	int:EGR2
Interaction	TLE3 interactions	CEBPB C15orf39 FOXA1 AHDC1 CIC SVEP1 JUND KMT2A CHD6 TAF4 DDX17 FBRS FBRSL1 TEAD1 NCOR1 ZSCAN18	1.18e-06	376	200	16	int:TLE3
Interaction	TLX2 interactions	MYCN CIC WIZ EHMT2 CHD6 FBRS FBRSL1 SKI NCOR1 GTF3C1	1.58e-06	142	200	10	int:TLX2
Interaction	CSNK2A1 interactions	BHLHE41 MYCN JPH4 ARID4B RPLP1 TRRAP RNF43 CIC PCGF6 EHMT2 ZC3H4 UBAC1 KMT2A DDX17 TCOF1 ZSCAN5A FBRS FBRSL1 GRIN2A RING1 NCOR1 UBE2O KLF1 MACF1 EIF3B MARCKS	3.09e-06	956	200	26	int:CSNK2A1
Interaction	VSX1 interactions	CIC WIZ EHMT2 BASP1 CHD6 FBRSL1 TFE3	4.05e-06	66	200	7	int:VSX1
Interaction	YWHAH interactions	ATXN2L CEBPB SPEG SPIRE1 WNK1 CIC RUSC2 SYNJ2 BASP1 KMT2A PLK1 WNK2 KIF13B CARMIL2 NEDD4L COBLL1 MEX3D SAMD4B BAG3 TBC1D25 DZIP1 SIK3 TFE3 KIAA1671 UNC119 TBC1D10B MACF1 MAPK7	4.58e-06	1102	200	28	int:YWHAH
Interaction	GATA2 interactions	MYCN ARID4B CIC WIZ EHMT2 CHD6 TAL1 FBRS FBRSL1 RING1 NCOR1	5.05e-06	199	200	11	int:GATA2
Interaction	HDAC1 interactions	BHLHE41 MYCN CEBPB ARID4B C15orf39 CIC CASZ1 PWWP2A PCGF6 WIZ EHMT2 KMT2A TAL1 BAHCC1 DDX17 UBR4 GPS1 BAG3 FBRS CBFA2T3 TFE3 RING1 KIAA1671 NCOR1 KLF1 NACC2 KLF13 CROCC	5.07e-06	1108	200	28	int:HDAC1
Interaction	KLF8 interactions	ARID4B CIC ZNF771 PCGF6 WIZ EHMT2 TAF4 TAF5 FBRS FBRSL1 TFE3 RING1 TRIM33 EIF3B	5.59e-06	329	200	14	int:KLF8
Interaction	H3-3A interactions	MYCN ARID4B TRRAP CIC CASZ1 PWWP2A PCGF6 WIZ EHMT2 KCNQ1 KMT2A TAF4 SAMD1 CENPT GPS1 NIBAN2 TEAD1 TFE3 RING1 GTF3C1 CBX6 ZSCAN18	5.69e-06	749	200	22	int:H3-3A
Interaction	LYL1 interactions	TAL1 CBFA2T3 TRIM33 LYL1	6.27e-06	13	200	4	int:LYL1
Interaction	CDC16 interactions	C15orf39 DUS3L SCAF1 TAF4 TAF5 PLK1 SAMD1 TCOF1 TUBGCP6 TRIM33 NCOR1 GPR156	6.76e-06	246	200	12	int:CDC16
Interaction	CRX interactions	ARID4B C15orf39 PCGF6 WIZ EHMT2 BAHCC1 TBX6 FBRS FBRSL1 TEAD1 SKI TRIM33	9.34e-06	254	200	12	int:CRX
Interaction	TEAD1 interactions	ARID4B TRRAP CIC WIZ EHMT2 FBRSL1 TEAD1 SKI RING1 NCOR1	1.08e-05	176	200	10	int:TEAD1
Interaction	YY1 interactions	MYCN ATXN2L ARID4B TRRAP CIC PCGF6 JUND WIZ EHMT2 KMT2A TAF4 TAF5 NEDD4L TEAD1 RING1 GTF3C1	1.29e-05	454	200	16	int:YY1
Interaction	SCMH1 interactions	POLR2M TRRAP SAMD1 FBRS RING1 CBX6	1.54e-05	54	200	6	int:SCMH1
Interaction	CSNK2B interactions	BHLHE41 JPH4 CEBPB CENPB CIC PCGF6 WIZ EHMT2 ZC3H4 KMT2A PLK1 TCOF1 ZSCAN5A FBRS FBRSL1 GRIN2A RING1 UBE2O OGA	1.59e-05	625	200	19	int:CSNK2B
Interaction	YWHAG interactions	MYCN ATXN2L CEBPB SPEG SPIRE1 WNK1 TRRAP CIC RUSC2 SYNJ2 ARHGAP29 KMT2A GNAS PLK1 KIF13B DDX17 CARMIL2 NEDD4L COBLL1 SAMD4B BAG3 DZIP1 SIK3 TFE3 KIAA1671 UNC119 TBC1D10B MACF1 MAPK7	1.67e-05	1248	200	29	int:YWHAG
Interaction	CHAMP1 interactions	MYCN CEBPB AHDC1 CIC PCGF6 WIZ EHMT2 GTPBP1 TRIM33	1.74e-05	148	200	9	int:CHAMP1
Interaction	GATA3 interactions	MYCN CEBPB FOXA1 CIC WIZ FUBP1 TAL1 FBRSL1 RING1 NCOR1	1.82e-05	187	200	10	int:GATA3
Interaction	ELF4 interactions	ARID4B TRRAP CIC PCGF6 EHMT2 TAF4 TAF5 TRIM33	1.95e-05	115	200	8	int:ELF4
Interaction	DCAF7 interactions	FOXA1 CIC SOCS7 PCGF6 PLK1 FBRS FBRSL1 SKI RING1 KIAA1671 TRIM33 NCOR1 CBX6 KNDC1	1.97e-05	368	200	14	int:DCAF7
Interaction	TBXT interactions	ARID4B CIC WIZ EHMT2 FBRS FBRSL1 RING1 NCOR1	2.08e-05	116	200	8	int:TBXT
Interaction	RUNX1 interactions	CEBPB CIC FUBP1 PKD1 KMT2A TAL1 DDX17 BAG3 BTBD2 CBFA2T3 RING1 TRIM33 NCOR1	2.26e-05	324	200	13	int:RUNX1
Interaction	IRF8 interactions	CEBPB ARID4B CIC EHMT2 GPS1 TFE3	2.33e-05	58	200	6	int:IRF8
Interaction	KLF12 interactions	ARID4B TRRAP CIC PCGF6 WIZ EHMT2 KMT2A CHD6 TFE3 GTF3C1	2.50e-05	194	200	10	int:KLF12
Interaction	ELK3 interactions	ARID4B CIC PCGF6 WIZ EHMT2 CHD6 TAF4 TAF5	2.66e-05	120	200	8	int:ELK3
Interaction	SIN3A interactions	CEBPB ARID4B CIC PWWP2A FUBP1 KMT2A TAL1 UBR4 TEAD1 SKI NCOR1 KLF1 KLF13 OGA	2.81e-05	380	200	14	int:SIN3A
Interaction	SOX2 interactions	ATXN2L CEBPB ARID4B MAP1A AHDC1 CIC LACTB JUND WIZ EHMT2 FUBP1 KMT2A CHD6 DDX17 MEX3D SAMD4B UBR4 GPS1 BAG3 FBRS JPH2 PBX4 TEAD1 FRAT2 TFE3 KIAA1671 TRIM33 NCOR1 ARHGEF40 GTF3C1 MACF1	2.86e-05	1422	200	31	int:SOX2
Interaction	CNTNAP2 interactions	MAP1A RRBP1 AMER2 BASP1 SYN1 WNK2 GRIN2A PALM MACF1	2.93e-05	158	200	9	int:CNTNAP2
Interaction	RING1 interactions	MYCN CIC PCGF6 EHMT2 KIF13B FBRS FBRSL1 TEAD1 RING1 CBX6	3.39e-05	201	200	10	int:RING1
Interaction	DEFB125 interactions	ZZEF1 UBAC1 UBR4 MIB2	4.03e-05	20	200	4	int:DEFB125
Interaction	IKZF5 interactions	AHDC1 CIC WIZ MIB2 TFE3 UBE2O	4.50e-05	65	200	6	int:IKZF5
Interaction	NFIC interactions	CEBPB ARID4B FOXA1 CIC WIZ EHMT2 FBRS FBRSL1 TEAD1 NCOR1	4.91e-05	210	200	10	int:NFIC
Interaction	YWHAE interactions	MYCN ATXN2L CEBPB SPIRE1 WNK1 RNF43 CIC RUSC2 SYNJ2 SYN1 KMT2A TAF4 WNK2 KIF13B CARMIL2 NEDD4L COBLL1 SAMD4B BAG3 TACC2 SIK3 RGS3 TFE3 KIAA1671 VPS9D1 UBE2O MACF1 MAPK7	4.94e-05	1256	200	28	int:YWHAE
Interaction	RPS6KA6 interactions	RPLP1 CENPB WNK1 UBAC1 TRIM33 DHX34	5.35e-05	67	200	6	int:RPS6KA6
Interaction	SP7 interactions	MYCN ARID4B C15orf39 CIC WIZ EHMT2 FUBP1 FBRS FBRSL1 RING1 TRIM33 NCOR1	5.48e-05	304	200	12	int:SP7
Interaction	MYB interactions	CEBPB CIC PCGF6 WIZ EHMT2 KMT2A SKI NCOR1	5.56e-05	133	200	8	int:MYB
Interaction	PTPN14 interactions	JPH4 RNF43 SOCS7 PLK1 KIF13B SAMD4B GPS1 BAG3 MARCKS	7.10e-05	177	200	9	int:PTPN14
Interaction	ZNF460 interactions	ZNF142 CENPB ZNF324 ZNF316 RGS3 TRIM33 UBE2O GPR156	7.21e-05	138	200	8	int:ZNF460
Interaction	PAX6 interactions	ARID4B CIC PCGF6 WIZ EHMT2 CHD6 VCX2 FBRS FBRSL1 RGS3 RING1 NCOR1 GTF3C1	7.88e-05	366	200	13	int:PAX6
Interaction	ERG interactions	ARID4B C15orf39 CIC SYN1 UBR4 FBRS FBRSL1 RING1 TRIM33 NCOR1	8.11e-05	223	200	10	int:ERG
Interaction	H3C1 interactions	ARID4B RRBP1 FOXA1 ZZEF1 TRRAP PCGF6 WIZ EHMT2 BASP1 ZC3H4 KMT2A TAF4 TAF5 CENPT COBLL1 UBR4 TFE3 TRIM33 NCOR1 GTF3C1 CBX6 PDZD2	9.36e-05	901	200	22	int:H3C1
Interaction	KHDRBS1 interactions	MYCN ATXN2L CEBPB TSPOAP1 TRRAP RNF43 CIC RUSC2 FUBP1 DDX17 COBLL1 UBE2O CBX6	9.53e-05	373	200	13	int:KHDRBS1
Interaction	HNF4A interactions	ARID4B TRRAP CIC WIZ EHMT2 PNRC1 TAF4 TAF5 RING1 TRIM33 NCOR1	9.98e-05	275	200	11	int:HNF4A
Interaction	EN1 interactions	ARID4B CENPB CIC WIZ KMT2A RING1 NCOR1	1.15e-04	110	200	7	int:EN1
Interaction	YWHAZ interactions	MYCN ATXN2L CEBPB SPEG SPIRE1 WNK1 CIC RUSC2 ARHGAP29 SYN1 KMT2A WNK2 KIF13B CARMIL2 NEDD4L COBLL1 SAMD4B BAG3 TACC2 DZIP1 SIK3 RGS3 TFE3 KIAA1671 NCOR1 MACF1 MAPK7 MARCKS	1.15e-04	1319	200	28	int:YWHAZ
Interaction	SMARCC1 interactions	MYCN CEBPB ARID4B STK11IP TRRAP CIC FUBP1 KMT2A TAF10 GPS1 TRIM33 NCOR1 KLF1	1.27e-04	384	200	13	int:SMARCC1
Interaction	MYOD1 interactions	BHLHE41 ARID4B TRRAP WIZ EHMT2 RING1 TRIM33 NCOR1 UBE2O	1.43e-04	194	200	9	int:MYOD1
Interaction	HDAC2 interactions	MYCN CEBPB ARID4B WNK1 CIC CASZ1 PWWP2A PCGF6 WIZ EHMT2 FUBP1 KMT2A PLK1 TAL1 DDX17 BAG3 CBFA2T3 TFE3 NCOR1 NACC2 EIF3B	1.47e-04	865	200	21	int:HDAC2
Interaction	GSK3B interactions	BHLHE41 CEBPB RPLP1 MAP1A CENPB RRBP1 RNF43 BASP1 FUBP1 ARHGAP29 CHD6 GPS1 NIBAN2 FRAT2 KIAA1671 UBE2O MACF1 EIF3B OGA IGSF21 DHX34	1.54e-04	868	200	21	int:GSK3B
Interaction	KLF15 interactions	ARID4B CIC ZNF771 EHMT2 TAF4 TAF5 FBRS SKI RING1 NCOR1 EIF3B	1.59e-04	290	200	11	int:KLF15
Interaction	RAPSN interactions	ZZEF1 UBR4 BAG3 MACF1	1.60e-04	28	200	4	int:RAPSN
Interaction	H3-4 interactions	CEBPB FOXA1 TRRAP AHDC1 PCGF6 EHMT2 KMT2A CHD6 TAF4 TAF5 TAF10 JPH2 RING1 CBX6	1.62e-04	448	200	14	int:H3-4
Interaction	TLX3 interactions	ARID4B C15orf39 CIC WIZ EHMT2 CHD6 FBRS FBRSL1 TFE3 RING1 NCOR1	1.64e-04	291	200	11	int:TLX3
Interaction	SOX7 interactions	C15orf39 CASZ1 WIZ BAHCC1 FBRS TRIM33	1.66e-04	82	200	6	int:SOX7
Interaction	SOX6 interactions	ARID4B C15orf39 CIC TAF4 FBRS FBRSL1 RING1 NCOR1	1.77e-04	157	200	8	int:SOX6
Interaction	ZEB1 interactions	RPLP1 USP42 EHMT2 DDX17 UBR4 TEAD1 GTPBP1 NCOR1 UBE2O	1.80e-04	200	200	9	int:ZEB1
Interaction	TRIM33 interactions	RRBP1 FOXA1 TRRAP FUBP1 PLK1 TAL1 KIF13B DDX17 CBFA2T3 SKI TRIM33 NCOR1 EIF3B LYL1	1.82e-04	453	200	14	int:TRIM33
Interaction	SKIL interactions	CEBPB ZZEF1 SVEP1 SKI TRIM33 NCOR1 MACF1	1.87e-04	119	200	7	int:SKIL
Interaction	IRF5 interactions	GPS1 GTPBP1 RGS3 NCOR1 OGA	1.95e-04	54	200	5	int:IRF5
Interaction	CBX8 interactions	MYCN CEBPB CENPB PCGF6 KMT2A FBRS RING1 UNC119 CBX6 OGA	2.00e-04	249	200	10	int:CBX8
Interaction	ACTC1 interactions	RPLP1 SPIRE1 TRRAP CIC WIZ BASP1 ZC3H4 FUBP1 TAF10 WNK2 DDX17 TCOF1 COBLL1 MIB2 TFE3 UBE2O AATK EIF3B	2.01e-04	694	200	18	int:ACTC1
Interaction	POLR1E interactions	MYCN CEBPB POLR2M FOXA1 TRRAP CASZ1 WIZ EHMT2 KMT2A CHD6 TCOF1 GTF3C1	2.06e-04	350	200	12	int:POLR1E
Interaction	PRNP interactions	MYCN POLR2M CIC LACTB AMER2 AFAP1L2 USP42 FUBP1 SYN1 TAF4 BSN TAF10 SAMD1 ZSCAN5A SAMD4B UBR4 DUSP7 GPS1 ZNF316 IRGQ SIK3 TRIM33 NCOR1 UBE2O MACF1	2.13e-04	1158	200	25	int:PRNP
Interaction	MAX interactions	MYCN CEBPB ARID4B TRRAP PCGF6 WIZ EHMT2 TCOF1 TEAD1 RING1	2.13e-04	251	200	10	int:MAX
Interaction	CBX4 interactions	MYCN ATXN2L PCGF6 WIZ EHMT2 KMT2A FBRS RING1 CBX6	2.16e-04	205	200	9	int:CBX4
Interaction	SNRNP40 interactions	MYCN CEBPB AHDC1 SCAF1 WIZ USP42 ZC3H4 FUBP1 KMT2A TAF4 DDX17 CENPT TENT4B TCOF1 GPS1 ZNF316 NCOR1	2.18e-04	637	200	17	int:SNRNP40
Interaction	SMARCA4 interactions	MYCN CEBPB ARID4B RRBP1 STK11IP TRRAP CIC TAF10 TENT4B SIK3 TRIM33 NCOR1 UBE2O KLF1	2.22e-04	462	200	14	int:SMARCA4
Interaction	FBL interactions	MYCN CEBPB RRBP1 TRRAP AHDC1 CIC WIZ ZNF324 DDX17 TENT4B TCOF1 ZNF316 TFE3 UBE2O ARHGEF40 GTF3C1 CHCHD2	2.26e-04	639	200	17	int:FBL
Interaction	WNK3 interactions	WNK1 STK39 WNK2 NEDD4L COBLL1	2.32e-04	56	200	5	int:WNK3
Interaction	SPATA1 interactions	C15orf39 WNK1 WNK2 UBR4	2.40e-04	31	200	4	int:SPATA1
Interaction	NHLH1 interactions	ARID4B PCGF6 WIZ EHMT2 KMT2A UBE2O	2.44e-04	88	200	6	int:NHLH1
Interaction	ZNF324B interactions	AHDC1 ZNF324 ZNF316 RGS3 TRIM33 LTBP2	2.60e-04	89	200	6	int:ZNF324B
Interaction	SAP30 interactions	MYCN ARID4B CIC PWWP2A KMT2A BAHCC1 GPS1 NCOR1	2.70e-04	167	200	8	int:SAP30
Interaction	KCTD13 interactions	ATXN2L RPLP1 MAP1A SPIRE1 RRBP1 ADD2 LACTB MAPK8IP3 AP1G1 AJM1 SYN1 KMT2A BSN WNK2 DDX17 CARMIL2 NEDD4L PRR36 GRIN2A GTPBP1 PITPNM1 GAS2L1 UBE2O CRACDL KNDC1 PALM MACF1 CROCC	2.86e-04	1394	200	28	int:KCTD13
Interaction	ZNF638 interactions	MYCN JPH4 CEBPB TRRAP RNF43 FUBP1 KIF13B TBC1D25 TFE3 CHCHD2	2.92e-04	261	200	10	int:ZNF638
Interaction	DYRK1B interactions	TRRAP CIC PLK1 SKI ARHGEF40 KNDC1	2.93e-04	91	200	6	int:DYRK1B
Interaction	SCML1 interactions	JPH4 PLK1 COBLL1 CBX6 GPR156	2.97e-04	59	200	5	int:SCML1
Interaction	H1-4 interactions	MYCN CEBPB RPLP1 ZNF771 SCAF1 EHMT2 KMT2A BSN FMNL1 COL5A1 TENT4B TCOF1 TACC2 PRX TFE3 GOLGA8B MACF1	3.06e-04	656	200	17	int:H1-4
Interaction	YWHAQ interactions	MYCN ATXN2L CEBPB SPEG SPIRE1 WNK1 RNF43 CIC RUSC2 USP42 SYNJ2 KMT2A KIF13B CARMIL2 NEDD4L COBLL1 SAMD4B BAG3 DZIP1 SIK3 RGS3 TFE3 KIAA1671 MACF1	3.11e-04	1118	200	24	int:YWHAQ
Interaction	ZKSCAN8 interactions	MYCN CENPB CIC RGS3 UBE2O CBX6 ZSCAN18	3.22e-04	130	200	7	int:ZKSCAN8
Interaction	NOM1 interactions	MYCN GPR182 FOXA1 CIC UBE2O CHCHD2 MAPK7	3.22e-04	130	200	7	int:NOM1
Interaction	PAX9 interactions	ARID4B C15orf39 CIC EHMT2 FBRS FBRSL1 NCOR1	3.22e-04	130	200	7	int:PAX9
Interaction	TAL1 interactions	TRRAP TAL1 UBR4 CBFA2T3 TRIM33 LYL1	3.30e-04	93	200	6	int:TAL1
Interaction	ZNF24 interactions	CEBPB CIC ZSCAN1 ZC3H4 RGS3 UNC119 UBE2O ZSCAN18	3.55e-04	174	200	8	int:ZNF24
Interaction	TLX1 interactions	ARID4B CIC WIZ EHMT2 FBRS FBRSL1 RING1 NCOR1	3.69e-04	175	200	8	int:TLX1
Interaction	TRIM52 interactions	CENPB TRRAP PCGF6 ZNF324 TRIM33 NCOR1 GTF3C1	3.70e-04	133	200	7	int:TRIM52
Interaction	SOX17 interactions	CIC WIZ EHMT2 FBRS TRIM33 NCOR1	3.70e-04	95	200	6	int:SOX17
Interaction	CIC interactions	BHLHE41 CEBPB ARID4B CIC PCGF6 WIZ EHMT2 TAF4 TAF5 PLK1 DDX17 TEAD1 GTPBP1 SKI RING1 GTF3C1 EIF3B	4.10e-04	673	200	17	int:CIC
Interaction	MECP2 interactions	MYCN ATXN2L MAP1A TRRAP AHDC1 ADD2 WIZ USP42 ZC3H4 FGD1 ZNF324 CHD6 PLK1 DDX17 NEDD4L TCOF1 SIK3 CBFA2T3 SKI NCOR1 TBC1D10B GTF3C1 MACF1 EIF3B TNXB MARCKS	4.40e-04	1287	200	26	int:MECP2
Interaction	H3C3 interactions	TRRAP CIC PWWP2A PCGF6 WIZ EHMT2 KMT2A CHD6 SAMD1 TEAD1 RING1 UBE2O GTF3C1 ZSCAN18	4.45e-04	495	200	14	int:H3C3
Interaction	KDM1A interactions	MYCN CEBPB C15orf39 TRRAP CIC WIZ EHMT2 ARHGAP29 CHD6 TAL1 SAMD1 ZSCAN5A UBR4 BAG3 FBRS PBX4 CBFA2T3 KIAA1671 UNC119 NCOR1 GTF3C1	4.55e-04	941	200	21	int:KDM1A
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	DUS3L JUND WIZ TMEM259 SAMD1 PRR36 MEX3D PBX4 BTBD2 KLF1 PALM PKN1 LYL1	9.68e-05	797	212	13	chr19p13
Cytoband	1p36.13	AHDC1 UBR4 CROCC IGSF21	1.35e-04	56	212	4	1p36.13
Cytoband	2q35	ZNF142 SPEG STK11IP CDK5R2	5.06e-04	79	212	4	2q35
Cytoband	19q13.43	ZSCAN1 ZNF324 ZSCAN5A ZSCAN18	7.29e-04	87	212	4	19q13.43
Cytoband	Ensembl 112 genes in cytogenetic band chr9q34	IER5L AJM1 UBAC1 COL5A1 RALGDS NIBAN2 NACC2	8.39e-04	325	212	7	chr9q34
GeneFamily	Variable charge X/Y family	VCX3B VCX2 VCX3A VCY VCX	8.35e-11	6	124	5	368
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF142 KLF14 CASZ1 ZNF771 ZSCAN1 WIZ ZNF324 INSM2 ZSCAN5A ZNF316 KLF1 KLF13 ZSCAN18 ZFHX2 ZNF853	1.19e-04	718	124	15	28
GeneFamily	Zinc fingers C2H2-type\|Kruppel like factors	KLF14 KLF1 KLF13	2.38e-04	18	124	3	624
GeneFamily	Basic helix-loop-helix proteins	BHLHE41 MYCN TAL1 TFE3 LYL1	9.65e-04	110	124	5	420
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYBPHL MYBPC3	1.27e-03	8	124	2	658
Coexpression	ZHONG_PFC_C3_ASTROCYTE	MYCN JPH4 PSD TSPOAP1 STK11IP CIC BASP1 PKD1 ZNF324 KMT2A ARHGAP20 ZNF316 FBRSL1 CBFA2T3 TUBGCP6 GOLGA8B GOLGA8A	1.74e-08	389	209	17	M39102
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	JPH4 TSPOAP1 SPEG KLHL35 CASZ1 CCDC85A ADD2 AMER2 BASP1 BSN TAL1 CNGB1 NEDD4L IRGQ AATK GPR137C ZFHX2 GOLGA8B	4.15e-08	465	209	18	M39066
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	ZNF142 CEBPB C15orf39 DUS3L ZZEF1 TRRAP CASZ1 MAPK8IP3 TMEM259 UBR4 GPS1 PBX4 NIBAN2 SIK3 BTBD2 FRAT2 PITPNM1 TUBGCP6 VPS9D1 UNC119 KLF13 CBX6 ZSCAN18 GOLGA8B HERPUD1	7.21e-08	905	209	25	M40865
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING	VWA5B2 RRBP1 STK11IP TRRAP ZNF771 JUND EHMT2 TMEM259 BASP1 AJM1 ZNF324 TAF5 BSN BAHCC1 RALGDS SAMD4B NIBAN2 RING1 UBE2O ARHGEF40 NACC2 GPR137C ZFHX2 PALM	7.23e-07	954	209	24	MM3689
Coexpression	NAGY_TFTC_COMPONENTS_HUMAN	TRRAP TAF4 TAF5 TAF10	1.10e-05	18	209	4	M2974
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	CEBPB DUS3L ZZEF1 CASZ1 MAPK8IP3 JUND RALGDS PBX4 NIBAN2 SIK3 BTBD2 PITPNM1 TUBGCP6 UNC119 CBX6 ZSCAN18 HERPUD1	1.46e-05	634	209	17	M40866
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	JPH4 PSD ANKRD9 AHDC1 CASZ1 CCDC85A SOCS7 BASP1 BSN TAL1 CNGB1 RALGDS IRGQ AATK GPR137C ZFHX2 GOLGA8B GOLGA8A	1.50e-05	703	209	18	M39070
Coexpression	PDGF_ERK_DN.V1_DN	MYCN CEBPB CIC ZNF324 PNRC1 FRAT2 PITPNM1 DHX34	2.72e-05	149	209	8	M2828
Coexpression	GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	CENPB JUND UBAC1 DDX17 DUSP7 FRAT2 NACC2 KLF13 LYL1	3.21e-05	198	209	9	M5861
Coexpression	GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP	C15orf39 BASP1 NEDD4L UBR4 SIK3 TFE3 UNC119 DHX34 MARCKS	3.21e-05	198	209	9	M4462
Coexpression	GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN	CENPB RRBP1 ARMCX2 CIC AP1G1 SAMD4B GPS1 BAG3 PRX	3.47e-05	200	209	9	M9074
Coexpression	FAN_EMBRYONIC_CTX_OLIG	MAP1A PIGG RRBP1 WNK1 PRR18 AMER2 SYNJ2 TBC1D12 STK39 TAF10 KIF13B RALGDS DUSP7 GRIN2A SIK3 RGS3 AATK KLF13	3.77e-05	754	209	18	M39037
Coexpression	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	ARMCX2 TAL1 COL5A1 DDX17 BAG3 PDZD2	4.72e-05	81	209	6	M17082
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_UP	BHLHE41 CEBPB ARID4B JUND BASP1 PNRC1 GNAS TACC2 SIK3 GTPBP1 TRIM33 HERPUD1 MARCKS	6.44e-05	445	209	13	M7928
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	MYCN CEBPB RRBP1 ARMCX2 FOXA1 JUND BASP1 KMT2A PNRC1 TAL1 BAG3 CBFA2T3 SKI NACC2 MACF1 LTBP2 MARCKS	7.25e-05	721	209	17	M1999
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	JPH4 PSD TSPOAP1 SPEG AHDC1 CASZ1 CCDC85A SOCS7 RUSC2 AMER2 BASP1 BSN TAL1 RALGDS NEDD4L IRGQ SIK3 AATK GPR137C ZFHX2 GOLGA8B GOLGA8A	7.98e-05	1106	209	22	M39071
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING	CEBPB RPLP1 CENPB RRBP1 CASZ1 JUND SAMD4B TACC2 NCOR1 CBX6 MACF1 OGA	8.33e-05	394	209	12	MM3724
Coexpression	BENPORATH_SUZ12_TARGETS	BHLHE41 KLF14 KLHL35 FOXA1 CASZ1 AMER2 IER5L INSM2 EIF4E3 GNAS ARHGAP20 BARX1 TAL1 CDK5R2 MLNR KCNH3 CRACDL CHRD LTBP2 IGSF21 PDZD2	8.86e-05	1035	209	21	M9898
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	ATXN2L TRRAP CIC MAPK8IP3 SCAF1 EHMT2 TMEM259 TCOF1 ZNF316 FBRSL1 EIF3B	9.21e-05	338	209	11	M17094
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	ZNF142 TSPOAP1 TRRAP PCGF6 EHMT2 FUBP1 TCOF1 ZNF316	1.20e-04	184	209	8	M19988
Coexpression	IVANOV_MUTATED_IN_COLON_CANCER	RNF43 NCOR1 MARCKS	1.35e-04	13	209	3	M5989
Coexpression	ZHONG_PFC_C3_MICROGLIA	JPH4 MAP1A TSPOAP1 ADD2 AMER2 FUBP1 PKD1 ZNF324 SAMD4B TACC2 KNDC1 GOLGA8A IGSF21	1.61e-04	488	209	13	M39104
Coexpression	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	JUND DZIP1 FRAT2 TRIM33 EIF3B	1.85e-04	66	209	5	M16347
Coexpression	GSE29618_MONOCYTE_VS_PDC_DN	MAP1A RRBP1 BAHCC1 COBLL1 CBFA2T3 GOLGA8B GOLGA8A HERPUD1	1.92e-04	197	209	8	M4946
Coexpression	GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	RRBP1 ZZEF1 MAPK8IP3 ZNF324 BAHCC1 IRGQ MACF1 GOLGA8A	1.92e-04	197	209	8	M8983
Coexpression	GSE13411_NAIVE_VS_MEMORY_BCELL_DN	BHLHE41 STK39 GNAS NEDD4L COBLL1 CBX6 GOLGA8A MARCKS	1.99e-04	198	209	8	M3246
Coexpression	GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP	ZNF142 C15orf39 JUND FUBP1 DDX17 TFE3 GPR153 CHCHD2	1.99e-04	198	209	8	M9534
Coexpression	GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP	CIC IER5L KCNQ1 PNRC1 NEDD4L TACC2 DZIP1 FRAT2	1.99e-04	198	209	8	M9035
Coexpression	GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	CENPB UBAC1 TAF4 DDX17 DUSP7 FRAT2 KLF13 LYL1	2.06e-04	199	209	8	M5874
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	JUND KMT2A CENPT TBC1D10B NACC2 CHCHD2 MACF1 PKN1	2.06e-04	199	209	8	M9964
Coexpression	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	C15orf39 KMT2A SIK3 GTPBP1 CBFA2T3 UNC119 KLF13 OGA	2.06e-04	199	209	8	M4460
Coexpression	GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP	ZZEF1 FUBP1 FMNL1 CENPT UBR4 GOLGA8B MACF1 GOLGA8A	2.13e-04	200	209	8	M9889
Coexpression	GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP	ATXN2L CEBPB TSPOAP1 SOCS7 SYN1 RALGDS HVCN1 SLC49A4	2.13e-04	200	209	8	M6456
Coexpression	GSE360_DC_VS_MAC_UP	TSPOAP1 AP1G1 BSN TAF10 FMNL1 UBR4 TFE3 GTF3C1	2.13e-04	200	209	8	M5172
Coexpression	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	BHLHE41 CENPB SPEG GPR182 DUS3L ZZEF1 AFAP1L2 GNAS PLK1 MIB2 NCOR1 CRLS1 ARHGEF40 CHRD PALM	2.28e-04	646	209	15	M2419
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2	MAP1A KLF14 SHC3 CCDC85A RUSC2 JUND SYN1 CHD6 WNK2 NEDD4L PRR36 ZNF316 MIB2 IRGQ AATK NACC2 KLF13 GPR137C CBX6 ZFHX2 MACF1 PKN1	4.97e-07	659	206	22	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2
ToppCell	Control-gd_T\|Control / Disease condition and Cell class	CEBPB JUND IER5L TMEM259 GNAS FMNL1 TENT4B PBX4 SIK3 CHCHD2 PKN1 OGA HERPUD1	1.24e-11	197	211	13	000b3269c152d80527b5ad9412dd4e71b73ef1ca
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN2L CEBPB CENPB JUND IER5L RALGDS SAMD4B DUSP7 JPH2 KLF13 CBX6	1.55e-09	186	211	11	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN2L CEBPB CENPB JUND IER5L RALGDS SAMD4B DUSP7 JPH2 KLF13 CBX6	1.84e-09	189	211	11	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CEBPB SPIRE1 SVEP1 JUND BASP1 PNRC1 ARHGAP20 SAMD4B UBR4 BAG3 SIK3	2.17e-09	192	211	11	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	COVID\|World / Condition, Cell_class and T cell subcluster	BHLHE41 CEBPB JUND IER5L BASP1 UBAC1 KCNQ1 GNAS TAF10 LYL1 MARCKS	3.32e-09	200	211	11	04a932fe2431e7886120c219ce666f90d3030a1c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPIRE1 SHC3 CASZ1 RPH3AL NEDD4L COBLL1 SLC26A9 TACC2 NIBAN2 PDZD2	3.23e-08	194	211	10	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARMCX2 AFAP1L2 EIF4E3 GNAS TBX4 COBLL1 CBFA2T3 LTBP2 MARCKS PDZD2	3.39e-08	195	211	10	7a32a8535c29b819dacba901d0658280a2631c94
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARMCX2 AFAP1L2 EIF4E3 GNAS TBX4 COBLL1 CBFA2T3 LTBP2 MARCKS PDZD2	3.39e-08	195	211	10	4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARMCX2 AFAP1L2 EIF4E3 GNAS TBX4 COBLL1 CBFA2T3 LTBP2 MARCKS PDZD2	3.56e-08	196	211	10	6708026bafd19c35c5c4e81911344d36a0f508cd
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD ADD2 BASP1 SYN1 BSN GRIN2A KCNH3 CRACDL GOLGA8A	2.85e-07	187	211	9	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD ADD2 BASP1 SYN1 BSN GRIN2A KCNH3 CRACDL GOLGA8A	2.85e-07	187	211	9	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD ADD2 BASP1 SYN1 BSN GRIN2A KCNH3 CRACDL GOLGA8A	2.85e-07	187	211	9	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PSD TSPOAP1 ADD2 SYN1 KMT2A BSN CDK5R2 CARMIL2 GRIN2A	3.26e-07	190	211	9	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KLF14 ARMCX2 AFAP1L2 EIF4E3 GNAS TBX4 LTBP2 MARCKS PDZD2	3.56e-07	192	211	9	063e119c4b58957643908f667e6cfd6f7517fd03
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BHLHE41 BASP1 TCOF1 COBLL1 CBFA2T3 HVCN1 LYL1 MARCKS SHISA8	3.89e-07	194	211	9	f0c113edb706d53792892115b67277a285219942
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADD2 SYN1 BSN ARHGAP20 CDK5R2 FMNL1 GRIN2A KCNH3 CRACDL	4.06e-07	195	211	9	ffbab350e67d9c4b66c0ab84550daec8b8139a27
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-Memory_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	BHLHE41 BASP1 TCOF1 COBLL1 CBFA2T3 HVCN1 LYL1 MARCKS SHISA8	4.24e-07	196	211	9	c450cd6b799932f5cce8326d1079114abeb71e95
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B\|lymph-node_spleen / Manually curated celltypes from each tissue	BHLHE41 BASP1 TCOF1 COBLL1 CBFA2T3 HVCN1 LYL1 MARCKS SHISA8	4.42e-07	197	211	9	9837bd2cc28b79147fb5d1997631ef953fd020e4
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BHLHE41 BASP1 TCOF1 COBLL1 CBFA2T3 HVCN1 LYL1 MARCKS SHISA8	4.42e-07	197	211	9	9bc5fbc59c600eba2a76a801091b69270bd7d161
ToppCell	mLN-(2)_B_cell-(22)_B_cell_memory\|mLN / shred on region, Cell_type, and subtype	BHLHE41 RPLP1 BASP1 COBLL1 CBFA2T3 HVCN1 LYL1 HERPUD1 MARCKS	4.61e-07	198	211	9	4d189df1db5b41306e9653436d7d7e75ff5afa06
ToppCell	mLN-B_cell-B_cell_memory\|mLN / Region, Cell class and subclass	BHLHE41 RPLP1 BASP1 COBLL1 CBFA2T3 HVCN1 LYL1 HERPUD1 MARCKS	4.61e-07	198	211	9	6dc155ee487abb1319a60a7a70e84c28c9851985
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BHLHE41 BASP1 COBLL1 CBFA2T3 HVCN1 LYL1 HERPUD1 MARCKS SHISA8	4.81e-07	199	211	9	1aa963ed5205d6d52262b1597a5d08707a95c3ca
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD MAP1A ANKRD9 INSM2 CDK5R2 FMNL1 PBX4 TBC1D25	1.14e-06	163	211	8	953a7db7e90a913e81002d2141fbbd5f1fdf2197
ToppCell	severe_influenza-B_memory\|World / disease group, cell group and cell class (v2)	BHLHE41 ADD2 BASP1 TCOF1 COBLL1 HVCN1 GPR156 SHISA8	1.71e-06	172	211	8	0ff38f9431cec73250c580a6010cb7891a3fe3f1
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 RRBP1 WNK1 JUND FMNL1 MACF1 OGA MARCKS	1.78e-06	173	211	8	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 RRBP1 WNK1 JUND FMNL1 MACF1 OGA MARCKS	1.78e-06	173	211	8	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 RRBP1 WNK1 JUND FMNL1 MACF1 OGA MARCKS	1.78e-06	173	211	8	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 RRBP1 WNK1 JUND FMNL1 MACF1 OGA MARCKS	1.94e-06	175	211	8	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	wk_08-11-Hematologic-Meg-ery-Primitive_erythrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	MAP1A ANKRD9 ADD2 UBAC1 TAL1 TEX13D KLF1 LYL1	2.30e-06	179	211	8	3c8046f43da5a02fa4278a7175b9cd8cf95b8e27
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Memory_B_cells\|bone_marrow / Manually curated celltypes from each tissue	BHLHE41 CCDC85A BASP1 COBLL1 HVCN1 LYL1 MARCKS SHISA8	2.82e-06	184	211	8	ffc9eec123de34a4f17ed27fe4f0a1b3cb84697f
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JUND BASP1 FMNL1 SIK3 HVCN1 HERPUD1 MARCKS SHISA8	2.94e-06	185	211	8	e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRR23C CCDC85A SYNJ2 ARHGAP29 TAL1 NIBAN2 RGS3 KIAA1671	3.18e-06	187	211	8	25efb82afe863a853ecdd781ad89026c993aaa67
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BHLHE41 JUND TCOF1 COBLL1 HVCN1 HERPUD1 MARCKS SHISA8	3.31e-06	188	211	8	229108e7e3db49e1cfd747d69e338394139d95b3
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B-Memory_B_cells\|GI_small-bowel / Manually curated celltypes from each tissue	BHLHE41 BASP1 COBLL1 CBFA2T3 HVCN1 LYL1 MARCKS SHISA8	3.31e-06	188	211	8	ab1384e6f71053946368502282aeebf1ba92d33e
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KLF14 ARMCX2 AFAP1L2 EIF4E3 GNAS LTBP2 MARCKS PDZD2	3.58e-06	190	211	8	979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BHLHE41 BASP1 TCOF1 COBLL1 CBFA2T3 HERPUD1 MARCKS SHISA8	3.58e-06	190	211	8	0db545a4cba7534bad2693e0d565cde7dbc7a586
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	MAPK8IP3 BASP1 TCOF1 COBLL1 CBFA2T3 HVCN1 SLC49A4 MARCKS	3.58e-06	190	211	8	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEBPB JUND RALGDS DUSP7 BAG3 JPH2 KLF13 LTBP2	3.72e-06	191	211	8	2f733d510a4862565a817f59829d8387d7ea26d9
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEBPB JUND RALGDS DUSP7 BAG3 JPH2 KLF13 LTBP2	3.72e-06	191	211	8	8691eba35793e4e90f93d50c2145847ee51289f7
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ARID4B AP1G1 KMT2A DDX17 PBX4 SIK3 MACF1 GOLGA8A	3.87e-06	192	211	8	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	356C-Lymphocytic-B_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BASP1 TCOF1 COBLL1 CBFA2T3 HVCN1 LYL1 HERPUD1 MARCKS	3.87e-06	192	211	8	f1ac7fa8159f573d140f0e4cbd15256dcb142980
ToppCell	356C-Lymphocytic-B_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BASP1 TCOF1 COBLL1 CBFA2T3 HVCN1 LYL1 HERPUD1 MARCKS	3.87e-06	192	211	8	1d7a5d15c76ae45551ce104327a2241fbf7d1827
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 ADD2 SYN1 BSN CDK5R2 GRIN2A KCNH3 CRACDL	4.02e-06	193	211	8	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 ADD2 SYN1 BSN CDK5R2 GRIN2A KCNH3 CRACDL	4.02e-06	193	211	8	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	normal_Lymph_Node-B_lymphocytes-Follicular_B_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	RPLP1 BASP1 TCOF1 COBLL1 HVCN1 LYL1 HERPUD1 MARCKS	4.18e-06	194	211	8	cd2485ba732ab32b33197bc8f78c755e098f1891
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	CASZ1 WNK2 NEDD4L JPH2 TACC2 RGS3 PDZD2 MYBPC3	4.18e-06	194	211	8	c3535f7cc0076653c72db582047cff053c322397
ToppCell	Mild/Remission-B_memory-0\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RPLP1 JUND BASP1 FMNL1 CBFA2T3 HERPUD1 MARCKS SHISA8	4.18e-06	194	211	8	4866093b50cdf895f06b60684cc3aaa9769aa4dc
ToppCell	severe-B_intermediate\|World / disease stage, cell group and cell class	JUND BASP1 TCOF1 COBLL1 CBFA2T3 HVCN1 HERPUD1 MARCKS	4.34e-06	195	211	8	ce4bd004ceb05a269387adfed255d7fa393afcc6
ToppCell	myeloid-Monocyte-CD14+_Monocyte\|myeloid / Lineage, cell class and subclass	CEBPB JUND BASP1 EIF4E3 NIBAN2 KCNH3 TBC1D10B ARHGEF40	4.34e-06	195	211	8	15ba9c5f6ecb6ae2c603e6b036eb92b00b46f13f
ToppCell	severe-B_intermediate\|severe / disease stage, cell group and cell class	JUND BASP1 TCOF1 COBLL1 CBFA2T3 HVCN1 HERPUD1 MARCKS	4.51e-06	196	211	8	8f59e51ca50bef4753f67cd1efdb02665805a120
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	ATXN2L WNK1 KMT2A GNAS TAF10 FMNL1 GTF3C1 KLF13	4.51e-06	196	211	8	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	3'_v3-Lung-Myeloid_Monocytic-Nonclassical_monocytes\|Lung / Manually curated celltypes from each tissue	C15orf39 ARHGAP29 SYN1 UNC119 CBX6 KNDC1 MAPK7 MARCKS	4.51e-06	196	211	8	7fe97109a5a06b35fc081a85f341ea78da131323
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	JUND KMT2A PNRC1 GNAS TAF10 DDX17 KLF13 MACF1	5.23e-06	200	211	8	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	E18.5-samps-Mesenchymal-Pericyte-pericyte_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PRR18 RUSC2 ZNF771 GPR137C ZSCAN18 CROCC PDZD2	7.87e-06	151	211	7	8ba15ab24fe2e71df0a2a7511ca451ad2376bd91
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1A SPEG PKD1 MYBPHL CBFA2T3 FRAT2 TNXB	1.01e-05	157	211	7	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	Control-APC-like-Monocyte-derived_macrophages\|Control / group, cell type (main and fine annotations)	TAF10 GPS1 GOLGA8R GAS2L1 PALM DHX34 HERPUD1	1.15e-05	160	211	7	463dd624ca5c375b6ff7c269f4ef4b9d74f4b669
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD MAP1A ANKRD9 INSM2 CDK5R2 TENT4B TBC1D25	1.30e-05	163	211	7	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPEG SPIRE1 SHC3 BASP1 WNK2 RALGDS HVCN1	1.40e-05	165	211	7	6dda1c7fd812792bd2e4fb1a7ccb82a3552b0a3b
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	AFAP1L2 SYNJ2 COL5A1 TBX4 GPR153 LTBP2 TNXB	1.52e-05	167	211	7	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUND INSM2 PNRC1 BARX1 COBLL1 HVCN1 MACF1	1.64e-05	169	211	7	c3a6179a64589a370108fea809b157839347759c
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	CCDC85A PNRC1 NEDD4L TACC2 TEAD1 KLF1 PDZD2	1.70e-05	170	211	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARID4B JUND BASP1 TCOF1 COBLL1 HVCN1 MARCKS	1.90e-05	173	211	7	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	Endothelial-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	MYCN GPR182 POLR2M ARHGAP29 TAL1 PALM TNXB	1.90e-05	173	211	7	a81992965137195d20fc498f750975303961a828
ToppCell	facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR182 ADD2 CENPT CBFA2T3 RGS3 ZFHX2 PALM	1.98e-05	174	211	7	42dfb6f42b72e40e203b3ef341117bccf3553d54
ToppCell	facs-Heart-RA-24m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR182 ADD2 CENPT CBFA2T3 RGS3 ZFHX2 PALM	1.98e-05	174	211	7	f04edf2ca6788875c9918611e416fb739924382e
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TMEM259 GNAS CHCHD2 PALM EIF3B ZNF853 GOLGA8A	2.05e-05	175	211	7	e99e145a152f534b75267ec492a252a0b814b4f8
ToppCell	IIH-CD8-antiviral_CD4\|IIH / Condition, Cell_class and T cell subcluster	PWWP2A STK39 KIF13B BAG3 NFS1 RGS3 TUBGCP6	2.21e-05	177	211	7	fe73608c40701eca88b260aeb5c0640d7bee72ba
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KLF14 ARMCX2 AFAP1L2 TBX4 LTBP2 MARCKS PDZD2	2.37e-05	179	211	7	56db12467b445f2b8ef92af50779eeab10413eb2
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BHLHE41 BASP1 COBLL1 CBFA2T3 HVCN1 LYL1 MARCKS	2.37e-05	179	211	7	fce1ba53815145f6248d4e90aedca3dad84e33e4
ToppCell	droplet-Spleen-nan-24m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 ADD2 UBAC1 TAL1 COL5A1 UBE2O KLF1	2.37e-05	179	211	7	f3f9c7e575bc4d9d3bce649b90254182e8f6aaec
ToppCell	droplet-Spleen-nan-24m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 ADD2 UBAC1 TAL1 COL5A1 UBE2O KLF1	2.37e-05	179	211	7	01e0b49e7f03ac9c3e6c34708ead300d27236b8b
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega\|lymph-node_spleen / Manually curated celltypes from each tissue	MYCN AHDC1 RNF43 TAL1 NIBAN2 CBFA2T3 KLF1	2.37e-05	179	211	7	957c08ad4b46eb4cc1717c45056fc3db50015fdc
ToppCell	HSPCs-Erythroblasts\|HSPCs / Lineage and Cell class	SPIRE1 ADD2 UBAC1 PLK1 TAL1 COL5A1 KLF1	2.55e-05	181	211	7	4ded490f190af7ace343acdf317edc7373484d08
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SPIRE1 COL5A1 TBX4 TACC2 GPR137C ZSCAN18 LTBP2	2.64e-05	182	211	7	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RRBP1 JUND KMT2A PNRC1 CBFA2T3 NCOR1 MACF1	2.83e-05	184	211	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BHLHE41 BASP1 COBLL1 CBFA2T3 HVCN1 HERPUD1 MARCKS	2.93e-05	185	211	7	3563dd39ec58d3273f95f5bb36b9ccdc0aafb63a
ToppCell	Immune-enucleated_erythrocyte\|World / Lineage, Cell type, age group and donor	ANKRD9 ADD2 UBAC1 TAL1 UBE2O KLF1 LYL1	3.03e-05	186	211	7	f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B\|GI_small-bowel / Manually curated celltypes from each tissue	BHLHE41 BASP1 COBLL1 CBFA2T3 HVCN1 LYL1 MARCKS	3.03e-05	186	211	7	a5c0bd4f6a7542f67d478dcdc0645ae6d927a395
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYCN GPR182 ARHGAP29 PALM MACF1 TNXB MARCKS	3.03e-05	186	211	7	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	BHLHE41 BASP1 COBLL1 HVCN1 LYL1 MARCKS SHISA8	3.13e-05	187	211	7	ea56cfca919a09db852b7ee5e42323f822962465
ToppCell	facs-Heart-LA-24m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR182 CENPT CBFA2T3 RGS3 ZFHX2 PALM LYL1	3.13e-05	187	211	7	7b13c3b67d66f3afb410141d5471c9e78a4d8623
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BHLHE41 BASP1 COBLL1 HVCN1 LYL1 MARCKS SHISA8	3.13e-05	187	211	7	43f81863063509337bd56a67010c62fb51109bd5
ToppCell	facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR182 CENPT CBFA2T3 RGS3 ZFHX2 PALM LYL1	3.13e-05	187	211	7	d9943e65eedab73d141eae524e2411653a751705
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CASZ1 WNK2 NEDD4L JPH2 TACC2 RGS3 MYBPC3	3.24e-05	188	211	7	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKRD9 ADD2 UBAC1 TAL1 UBE2O KLF1 LYL1	3.24e-05	188	211	7	f81099b5b3f1f85a28445bc663efcf73baccb2be
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 WNK1 TAL1 NEDD4L UBE2O KLF1 LYL1	3.24e-05	188	211	7	3467149de45b47a5015486ef94bec070e9c3ffc2
ToppCell	Multiple_Sclerosis-Lymphocyte-B-B_memory\|Multiple_Sclerosis / Disease, Lineage and Cell Type	BHLHE41 BASP1 COBLL1 HVCN1 HERPUD1 MARCKS SHISA8	3.24e-05	188	211	7	8da631b2c75441b7309f03e7d4c14f15f2367be6
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 WNK1 TAL1 NEDD4L UBE2O KLF1 LYL1	3.24e-05	188	211	7	da211e7fb62fff176aa9c39061aef9ab0af6079e
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BHLHE41 BASP1 COBLL1 HVCN1 LYL1 MARCKS SHISA8	3.24e-05	188	211	7	b6ae707b033a17c75ca81f9194631ead1b63d170
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 WNK1 TAL1 NEDD4L UBE2O KLF1 LYL1	3.24e-05	188	211	7	3c6c0eaadc474ebb218ae349b787c410f66177ab
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKRD9 ADD2 UBAC1 TAL1 UBE2O KLF1 LYL1	3.24e-05	188	211	7	05b3ade422beeb3db73d350fe192c21bfcfef188
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR182 ARHGAP29 CENPT CBFA2T3 RGS3 ZFHX2 PALM	3.35e-05	189	211	7	8e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17\|Lung / Manually curated celltypes from each tissue	ARID4B JUND KMT2A PNRC1 PBX4 SIK3 GOLGA8A	3.35e-05	189	211	7	f43960506ed3e699e910ec7711c1113e2e9b80d1
ToppCell	Fetal_29-31_weeks-Immune-enucleated_erythrocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANKRD9 ADD2 UBAC1 TAL1 UBE2O KLF1 LYL1	3.35e-05	189	211	7	1900e574870fc647bfa11c732a72f3d38aab717c
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KLHL35 GNAS CDK5R2 WNK2 MEX3D GPR153 PALM	3.35e-05	189	211	7	8e6b6025f5554672e26a5d19fe365acb4333789c
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	JUND CHD6 KIF13B TRIM33 KLF13 OGA HERPUD1	3.35e-05	189	211	7	2c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RRBP1 JUND KMT2A PNRC1 CHD6 GNAS DDX17	3.35e-05	189	211	7	a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SVEP1 COL5A1 TBX4 DZIP1 MACF1 MAPK7 MARCKS	3.35e-05	189	211	7	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KLF14 ARMCX2 AFAP1L2 TBX4 LTBP2 MARCKS PDZD2	3.35e-05	189	211	7	ca3a04c202afc32aa11d17154066ef7dc6d01405
ToppCell	droplet-Spleen-nan-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE1 ADD2 UBAC1 PLK1 TAL1 COL5A1 KLF1	3.47e-05	190	211	7	a273fc119baebc11020009c923beafeebb6428c9
Drug	fullerene C60	VWA5B2 ATXN2L ZNF142 CEBPB TSPOAP1 RNF43 LACTB MAPK8IP3 PWWP2A JUND IER5L EHMT2 TMEM259 BASP1 SYN1 KCNQ1 BSN TAL1 CNGB1 FMNL1 COL5A1 TBX4 SAMD4B DUSP7 NIBAN2 BTBD2 RGS3 PRX NCOR1 UBE2O GTF3C1 GPR153 GPR156 EIF3B LYL1 PDZD2 MYBPC3	1.09e-08	1498	201	37	ctd:C069837
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	AHDC1 RNF43 CIC WIZ TMEM259 FGD1 RPH3AL PRR36 FBRS NCOR1 CBX6 GPR153 DHX34	2.34e-08	197	201	13	3308_DN
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	ATXN2L CENPB WNK1 WIZ ZNF324 BAHCC1 CENPT TCOF1 BTBD2 UBE2O MAPK7	1.44e-06	196	201	11	1323_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	RRBP1 WNK1 CIC JUND WIZ ZNF324 DDX17 CENPT NEDD4L FBRS RGS3	1.44e-06	196	201	11	4826_DN
Drug	Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	ARMCX2 RUSC2 WIZ TMEM259 TBX6 KIF13B NEDD4L FBRS PRX MAPK7 OGA	1.51e-06	197	201	11	3582_DN
Drug	Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A	MAP1A SPEG RUSC2 JUND ZNF324 ZFHX2 MACF1 MAPK7 LYL1 MARCKS MYBPC3	1.67e-06	199	201	11	3264_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF142 SYNJ2 ZC3H4 TAF5 ZSCAN5A TACC2 CBFA2T3 FRAT2 RGS3 NACC2	5.27e-06	182	201	10	3630_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	SPEG SVEP1 ADD2 PNRC1 TAL1 TBX6 KIF13B SCLY CROCC OGA	7.35e-06	189	201	10	5587_UP
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	ATXN2L SPEG WNK1 FGD1 PRR36 VPS9D1 PALM CROCC OGA DHX34	9.25e-06	194	201	10	3377_DN
Drug	Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A	SPEG RRBP1 WNK1 MAPK8IP3 RUSC2 GNAS COL5A1 RALGDS RGS3 DHX34	9.25e-06	194	201	10	2118_DN
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A	CIC CASZ1 MAPK8IP3 ZNF324 FMNL1 TBX6 CENPT UNC119 TBC1D10B UBE2O	1.01e-05	196	201	10	3144_UP
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	RRBP1 ZNF771 SYNJ2 TMEM259 ZNF324 KIF13B RGS3 MAPK7 DHX34 MARCKS	1.01e-05	196	201	10	3183_DN
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	MAP1A BAHCC1 RALGDS CENPT NEDD4L BTBD2 KLF13 PALM OGA DHX34	1.06e-05	197	201	10	4295_DN
Drug	rapamycin; Down 200; 0.1uM; HL60; HG-U133A	ATXN2L ZNF142 RRBP1 ZZEF1 WIZ COL5A1 AATK GTF3C1 PALM MACF1	1.06e-05	197	201	10	362_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A	RUSC2 ZNF771 JUND PRR36 COBLL1 DUSP7 PITPNM1 ZSCAN18 LYL1 MYBPC3	1.06e-05	197	201	10	4299_UP
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	RRBP1 RNF43 SVEP1 MAPK8IP3 SYNJ2 FGD1 VPS9D1 ZFHX2 MACF1 LYL1	1.06e-05	197	201	10	7344_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	ATXN2L CIC WIZ SYNJ2 FGD1 BAHCC1 PITPNM1 VPS9D1 ZFHX2 OGA	1.11e-05	198	201	10	5583_DN
Drug	Butamben [94-25-7]; Down 200; 20.6uM; MCF7; HT_HG-U133A	RUSC2 ZNF771 WIZ SYNJ2 ZNF324 KIF13B FBRS LTBP2 MAPK7 DHX34	1.16e-05	199	201	10	6093_DN
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	CEBPB ARID4B ZC3H4 PNRC1 TAF5 PLK1 TACC2 FRAT2 HERPUD1	3.77e-05	183	201	9	7062_DN
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	CEBPB ARID4B ZC3H4 PNRC1 TAF4 TAF5 TACC2 FRAT2 TRIM33	4.46e-05	187	201	9	7080_DN
Drug	troglitazone; Down 200; 10uM; PC3; HT_HG-U133A	ATXN2L RUSC2 PNRC1 BAHCC1 BTBD2 UNC119 NCOR1 MAPK7 LYL1	4.65e-05	188	201	9	4456_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	RRBP1 WNK1 SYNJ2 ZNF324 KMT2A RALGDS DDX17 SKI DHX34	5.26e-05	191	201	9	6644_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	ATXN2L C15orf39 WNK1 WIZ GAS2L1 ARHGEF40 ZFHX2 LYL1 OGA	5.26e-05	191	201	9	3815_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A	BHLHE41 ATXN2L WNK1 AHDC1 CIC MAPK8IP3 JUND UNC119 GTF3C1	5.93e-05	194	201	9	6178_DN
Drug	Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A	CIC WIZ BAHCC1 DDX17 BTBD2 NFS1 NACC2 MAPK7 DHX34	5.93e-05	194	201	9	6070_DN
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A	CIC WIZ SYNJ2 TMEM259 ZNF324 KIF13B SCLY GPR153 LYL1	5.93e-05	194	201	9	2864_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	MAP1A ZZEF1 WIZ TMEM259 COBLL1 TRIM33 GAS2L1 KLF13 OGA	5.93e-05	194	201	9	4242_DN
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	FUBP1 ZNF324 CENPT TCOF1 SCLY TEAD1 UBE2O GTF3C1 CBX6	6.18e-05	195	201	9	1207_DN
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A	WNK1 ADD2 WIZ KMT2A DDX17 DZIP1 TEAD1 ZSCAN18 MYBPC3	6.42e-05	196	201	9	4291_UP
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	ATXN2L SPEG MAPK8IP3 RUSC2 BAHCC1 RPH3AL DZIP1 MAPK7 OGA	6.42e-05	196	201	9	4594_DN
Drug	Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A	ATXN2L WNK1 SYNJ2 TMEM259 COL5A1 DDX17 SKI ZFHX2 DHX34	6.42e-05	196	201	9	3435_UP
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A	RRBP1 AHDC1 CIC ZNF324 COL5A1 IRGQ PITPNM1 UNC119 TBC1D10B	6.42e-05	196	201	9	4793_DN
Drug	Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A	ATXN2L SPEG ZZEF1 WNK1 JUND COL5A1 TRIM33 ARHGEF40 MAPK7	6.42e-05	196	201	9	5461_UP
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A	C15orf39 RUSC2 SYNJ2 FGD1 ZNF324 PRR36 COBLL1 BTBD2 UNC119	6.68e-05	197	201	9	5449_DN
Drug	LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A	BHLHE41 ATXN2L MAPK8IP3 KCNQ1 DZIP1 RGS3 UNC119 GAS2L1 DHX34	6.68e-05	197	201	9	6175_DN
Drug	Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; HL60; HT_HG-U133A	RRBP1 ADD2 MAPK8IP3 TAL1 TEAD1 GAS2L1 LTBP2 DHX34 MYBPC3	6.68e-05	197	201	9	2488_UP
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A	C15orf39 MAPK8IP3 ZNF771 PNRC1 FMNL1 IRGQ SKI MACF1 DHX34	6.68e-05	197	201	9	2034_DN
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; HL60; HG-U133A	ZNF142 ZNF771 KMT2A IRGQ PITPNM1 ARHGEF40 CBX6 PKN1 OGA	6.95e-05	198	201	9	2020_DN
Drug	Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A	BHLHE41 RRBP1 RNF43 SVEP1 ADD2 SYNJ2 TBX6 VPS9D1 LYL1	6.95e-05	198	201	9	2638_UP
Drug	Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A	MYCN WNK1 ZNF324 TBX6 PRR36 BTBD2 FRAT2 GPR153 MAPK7	6.95e-05	198	201	9	6765_UP
Drug	Vitamin K2 [11032-49-8]; Down 200; 9uM; MCF7; HT_HG-U133A	ATXN2L CASZ1 ZNF771 WIZ BAHCC1 RPH3AL FBRS VPS9D1 LYL1	6.95e-05	198	201	9	3880_DN
Drug	0179445-0000 [211246-22-9]; Up 200; 1uM; PC3; HT_HG-U133A	MAP1A CASZ1 ZNF771 WIZ KMT2A DZIP1 ZSCAN18 DHX34 MYBPC3	6.95e-05	198	201	9	4292_UP
Drug	Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ATXN2L ZZEF1 AHDC1 RNF43 SOCS7 BAHCC1 SKI PALM LTBP2	6.95e-05	198	201	9	2848_UP
Drug	H-89, Dihydrochloride; Down 200; 0.5uM; MCF7; HT_HG-U133A	MAP1A C15orf39 RNF43 DDX17 FBRS PITPNM1 GPR153 MAPK7 CROCC	6.95e-05	198	201	9	6878_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MAP1A C15orf39 RRBP1 BAHCC1 COL5A1 RALGDS CENPT UNC119 GPR153	6.95e-05	198	201	9	7035_UP
Drug	exemestane; Down 200; 0.01uM; MCF7; HG-U133A	ZNF142 RRBP1 CIC MAPK8IP3 RALGDS DDX17 UBR4 GAS2L1 CBX6	7.22e-05	199	201	9	165_DN
Drug	Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; PC3; HT_HG-U133A	MYCN ATXN2L ZZEF1 SOCS7 ZNF771 DZIP1 PITPNM1 OGA DHX34	7.22e-05	199	201	9	5772_UP
Drug	THIP Hydrochloride; Down 200; 22.6uM; MCF7; HT_HG-U133A	RRBP1 AHDC1 WIZ SYNJ2 BAHCC1 COL5A1 FBRS GTPBP1 LTBP2	7.22e-05	199	201	9	6511_DN
Drug	Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; PC3; HT_HG-U133A	MAP1A MAPK8IP3 RUSC2 TMEM259 DDX17 PITPNM1 ZFHX2 MAPK7 OGA	7.22e-05	199	201	9	5753_DN
Drug	aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A	MYCN CIC MAPK8IP3 FGD1 KMT2A TAL1 TEAD1 MARCKS PDZD2	7.22e-05	199	201	9	6164_UP
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	ATXN2L WNK1 MAPK8IP3 RUSC2 COBLL1 UNC119 GPR153 PALM OGA	7.22e-05	199	201	9	3543_DN
Drug	Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A	SPEG ARMCX2 ZNF324 TAL1 DDX17 UNC119 ARHGEF40 PALM MACF1	7.22e-05	199	201	9	5509_UP
Drug	Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; PC3; HT_HG-U133A	MAP1A RRBP1 ZZEF1 AHDC1 JUND WIZ RALGDS SCLY DZIP1	7.22e-05	199	201	9	6743_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	ARMCX2 MAPK8IP3 WIZ FGD1 ZNF324 NEDD4L PRR36 VPS9D1 CROCC	7.22e-05	199	201	9	5219_UP
Drug	eg D	WNK1 ADD2 EHMT2 CBFA2T3	2.22e-04	34	201	4	CID000029544
Drug	Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A	C15orf39 RRBP1 WIZ DDX17 FRAT2 TRIM33 OGA HERPUD1	2.66e-04	187	201	8	3075_DN
Drug	2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A	ZC3H4 FMNL1 BAHCC1 DDX17 GTPBP1 ARHGEF40 CBX6 LYL1	2.86e-04	189	201	8	410_DN
Drug	PCI 5002	ARID4B C15orf39 SPIRE1 FOXA1 JUND AP1G1 RALGDS DDX17 NEDD4L ZSCAN5A BAG3 TACC2 SIK3 FRAT2 NACC2 KLF13 HERPUD1	2.98e-04	735	201	17	ctd:C568608
Drug	Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A	ATXN2L SVEP1 MAPK8IP3 WIZ SYNJ2 COL5A1 GPR153 CROCC	3.07e-04	191	201	8	7542_UP
Drug	cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Up 200; 100uM; MCF7; HT_HG-U133A_EA	MAP1A RRBP1 ZZEF1 MAPK8IP3 WIZ COL5A1 SIK3 OGA	3.29e-04	193	201	8	881_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	BHLHE41 CIC BAHCC1 GTPBP1 NCOR1 TBC1D10B PALM MAPK7	3.29e-04	193	201	8	3262_UP
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MAP1A ZZEF1 ZNF324 TBX6 RALGDS PALM PKN1 LYL1	3.29e-04	193	201	8	6223_UP
Drug	Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A	JUND TMEM259 FBRS PITPNM1 UNC119 GAS2L1 KLF13 MAPK7	3.29e-04	193	201	8	4225_DN
Drug	Decamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	RRBP1 ZZEF1 ADD2 SCLY KLF13 CHRD ZFHX2 MAPK7	3.29e-04	193	201	8	4174_UP
Drug	Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A	ZZEF1 WNK1 JUND KIF13B GAS2L1 KLF13 PALM MAPK7	3.29e-04	193	201	8	4240_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	ATXN2L C15orf39 JUND ZNF324 CBX6 GPR153 OGA DHX34	3.40e-04	194	201	8	6833_DN
Drug	Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A	WIZ TMEM259 FGD1 TBX6 COL5A1 COBLL1 KLF13 MARCKS	3.40e-04	194	201	8	4848_DN
Drug	Kawain [500-64-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A	SPEG MAPK8IP3 WIZ TMEM259 TBX6 NEDD4L PRX GPR153	3.40e-04	194	201	8	2299_UP
Drug	Phensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A	WNK1 JUND TMEM259 KIF13B DDX17 COBLL1 PALM MACF1	3.40e-04	194	201	8	3521_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	ATXN2L AHDC1 JUND WIZ ZNF324 RALGDS DUSP7 GAS2L1	3.40e-04	194	201	8	4335_DN
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; PC3; HT_HG-U133A	WIZ SYNJ2 TMEM259 FBRS DZIP1 SKI KLF13 MAPK7	3.40e-04	194	201	8	3795_DN
Drug	clofibrate; Up 200; 150uM; MCF7; HG-U133A	ATXN2L MAP1A RRBP1 WIZ SYNJ2 GRIN2A GAS2L1 MYBPC3	3.40e-04	194	201	8	263_UP
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A	C15orf39 AHDC1 RUSC2 JUND RPH3AL BTBD2 SKI NCOR1	3.52e-04	195	201	8	3512_DN
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	RRBP1 CIC RUSC2 FGD1 KMT2A SCLY UNC119 DHX34	3.52e-04	195	201	8	5024_UP
Drug	Betulin [473-98-3]; Down 200; 9uM; MCF7; HT_HG-U133A	RUSC2 TMEM259 BAHCC1 DDX17 SKI RGS3 PALM OGA	3.52e-04	195	201	8	3513_DN
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A	ATXN2L CEBPB TMEM259 PRR36 COBLL1 VPS9D1 KLF13 MYBPC3	3.52e-04	195	201	8	3712_UP
Drug	Etomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A	WNK1 CIC MAPK8IP3 RUSC2 WIZ PRR36 COBLL1 SCLY	3.52e-04	195	201	8	3519_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	MYCN MAP1A SVEP1 ADD2 GNAS PRX MAPK7 OGA	3.52e-04	195	201	8	5576_UP
Drug	Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A	ATXN2L WNK1 JUND WIZ FBRS KLF13 LYL1 OGA	3.52e-04	195	201	8	4235_DN
Drug	5140203; Down 200; 15uM; MCF7; HT_HG-U133A_EA	RRBP1 CIC PRR36 TBC1D10B GPR153 PALM DHX34 MARCKS	3.52e-04	195	201	8	908_DN
Drug	Bufexamac [2438-72-4]; Up 200; 18uM; HL60; HT_HG-U133A	ATXN2L RRBP1 RGS3 PRX VPS9D1 GPR153 CHRD DHX34	3.52e-04	195	201	8	2382_UP
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; HL60; HT_HG-U133A	TSPOAP1 RRBP1 AHDC1 CIC MAPK8IP3 ZSCAN5A MEX3D UNC119	3.52e-04	195	201	8	1336_DN
Drug	17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A	BHLHE41 ATXN2L RUSC2 BAHCC1 CENPT SCLY DZIP1 NCOR1	3.52e-04	195	201	8	6172_DN
Drug	ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A	ATXN2L RNF43 TAL1 TBX6 FBRS VPS9D1 MAPK7 MARCKS	3.65e-04	196	201	8	5926_UP
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A	SPEG WNK1 ADD2 TMEM259 FUBP1 TBX6 OGA MYBPC3	3.65e-04	196	201	8	4000_UP
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	RUSC2 FUBP1 ZNF324 KMT2A GNAS MEX3D NCOR1 MAPK7	3.65e-04	196	201	8	2056_DN
Drug	Sulfadoxine [2447-57-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A	WNK1 WIZ ZNF324 TBX6 VPS9D1 LTBP2 OGA DHX34	3.65e-04	196	201	8	7205_UP
Drug	5162773; Down 200; 7uM; MCF7; HT_HG-U133A_EA	SYNJ2 BAHCC1 COL5A1 RALGDS PRR36 BTBD2 GTPBP1 GPR153	3.65e-04	196	201	8	892_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	RRBP1 CASZ1 WIZ BAHCC1 KIF13B DDX17 NCOR1 GPR153	3.65e-04	196	201	8	7356_DN
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A	SYNJ2 KMT2A GNAS ZSCAN5A BTBD2 SKI UBE2O MACF1	3.65e-04	196	201	8	2978_DN
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A	BHLHE41 ATXN2L RRBP1 WIZ GNAS UNC119 GPR153 MAPK7	3.65e-04	196	201	8	4416_DN
Drug	Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	RRBP1 SVEP1 WIZ NEDD4L PITPNM1 ZFHX2 MAPK7 OGA	3.65e-04	196	201	8	5728_DN
Drug	Ethosuximide [77-67-8]; Down 200; 28.4uM; MCF7; HT_HG-U133A	BHLHE41 RNF43 TMEM259 BAHCC1 GPR153 ZFHX2 LYL1 DHX34	3.65e-04	196	201	8	2280_DN
Drug	Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A	BHLHE41 MAP1A RRBP1 WNK1 SVEP1 BAHCC1 LTBP2 OGA	3.65e-04	196	201	8	2800_UP
Drug	Cinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	BHLHE41 SCLY PRX AATK KLF1 PALM MAPK7 CROCC	3.65e-04	196	201	8	3175_UP
Drug	Bacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A	RRBP1 TMEM259 COL5A1 RALGDS DUSP7 SCLY RGS3 NCOR1	3.65e-04	196	201	8	7448_DN
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; PC3; HT_HG-U133A	RRBP1 MAPK8IP3 RUSC2 JUND UNC119 ZFHX2 PALM LYL1	3.65e-04	196	201	8	7300_UP
Drug	ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A	MAP1A WNK1 GNAS TAL1 TBX6 KIF13B KLF1 CHRD	3.77e-04	197	201	8	5565_UP
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A	ATXN2L WNK1 ZNF324 DDX17 COBLL1 UNC119 KLF13 ZFHX2	3.77e-04	197	201	8	5276_UP
Drug	Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A	C15orf39 WNK1 MAPK8IP3 RUSC2 FGD1 DDX17 PITPNM1 UNC119	3.77e-04	197	201	8	1803_DN
Disease	pseudohypoaldosteronism (implicated_via_orthology)	WNK1 STK39 WNK2	6.04e-06	6	200	3	DOID:4479 (implicated_via_orthology)
Disease	mean reticulocyte volume	ANKRD9 C15orf39 TRRAP IER5L TBC1D12 TAF4 PLK1 TAL1 PRXL2C TBX6 FBRSL1 GTPBP1 CBFA2T3 TRIM33 GTF3C1 KLF1 KLF13 LYL1	9.47e-06	799	200	18	EFO_0010701
Disease	sexual dimorphism measurement	ATXN2L ZNF142 KLF14 ZZEF1 ZC3H4 FUBP1 PKD1 KCNQ1 BSN TBX4 COBLL1 GRIN2A SIK3 TEAD1 NFS1 ARHGEF40 MACF1 LTBP2 CROCC HERPUD1 MYBPC3	2.22e-05	1106	200	21	EFO_0021796
Disease	frontotemporal dementia and/or amyotrophic lateral sclerosis-2 (implicated_via_orthology)	CHCHD2P9 CHCHD2	1.37e-04	3	200	2	DOID:0060214 (implicated_via_orthology)
Disease	Parkinson's disease 22 (implicated_via_orthology)	CHCHD2P9 CHCHD2	1.37e-04	3	200	2	DOID:0080504 (implicated_via_orthology)
Disease	spinal muscular atrophy, Jokela type (implicated_via_orthology)	CHCHD2P9 CHCHD2	1.37e-04	3	200	2	DOID:0081356 (implicated_via_orthology)
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ATXN2L KLF14 ZZEF1 ZC3H4 EIF4E3 TAL1 COBLL1 MIB2 KLF13 MACF1	2.04e-04	364	200	10	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	platelet component distribution width	ZZEF1 WNK1 SVEP1 PWWP2A AFAP1L2 SYNJ2 GNAS COBLL1 BTBD2 SKI VPS9D1 TRIM33 UBE2O MACF1 TNXB	2.13e-04	755	200	15	EFO_0007984
Disease	cystic fibrosis-related diabetes	CEBPB SLC26A9	2.72e-04	4	200	2	EFO_0801077
Disease	platelet crit	BHLHE41 ARID4B MAP1A ANKRD9 RRBP1 PWWP2A TBC1D12 ARHGAP29 KCNQ1 JPH2 NIBAN2 BTBD2 SKI ARHGEF40 CBX6 CHRD LYL1	2.84e-04	952	200	17	EFO_0007985
Disease	viral infectious disease (implicated_via_orthology)	CEBPB EHMT2	4.51e-04	5	200	2	DOID:934 (implicated_via_orthology)
Disease	Cone-Rod Dystrophies	AIPL1 UNC119	4.51e-04	5	200	2	C4085590
Disease	sleep efficiency	GOLGA8B GOLGA8A	4.51e-04	5	200	2	EFO_0803364
Disease	cholesterol to total lipids in large LDL percentage	COBLL1 SIK3 HERPUD1 MYBPC3	5.71e-04	56	200	4	EFO_0022235
Disease	C-reactive protein measurement	ATXN2L MAP1A ZZEF1 MAPK8IP3 PKD1 TAF4 BSN COBLL1 ZNF316 PRR30 PBX4 MIB2 GTPBP1 NCOR1 CBX6 MACF1 ZNF853 HERPUD1 MYBPC3	5.89e-04	1206	200	19	EFO_0004458
Disease	myeloperoxidase measurement	TSPOAP1 RRBP1 TNXB	7.11e-04	26	200	3	EFO_0005243
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	EHMT2 COBLL1 SIK3 HERPUD1	7.42e-04	60	200	4	EFO_0021898
Disease	serum albumin measurement	MAP1A ZZEF1 SVEP1 SCAF1 EIF4E3 BSN COBLL1 PBX4 SIK3 KLF13 MACF1 MYBPC3	7.67e-04	592	200	12	EFO_0004535
Disease	phospholipids in large VLDL measurement	KLF14 COBLL1 SIK3 HERPUD1	8.40e-04	62	200	4	EFO_0022169
Disease	total lipids in very large VLDL measurement	KLF14 COBLL1 SIK3 HERPUD1	8.40e-04	62	200	4	EFO_0022313
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	EHMT2 COBLL1 SIK3 HERPUD1	8.40e-04	62	200	4	EFO_0022263
Disease	severe acute respiratory syndrome, COVID-19	POLR2M CCDC85A SYNJ2 BASP1 PRR27 PALM GOLGA8B LTBP2 GOLGA8A PDZD2	1.01e-03	447	200	10	EFO_0000694, MONDO_0100096
Disease	total lipids in large VLDL	KLF14 COBLL1 SIK3 HERPUD1	1.12e-03	67	200	4	EFO_0022175
Disease	triglycerides in very small VLDL measurement	EHMT2 COBLL1 SIK3 HERPUD1	1.19e-03	68	200	4	EFO_0022144
Disease	triglycerides to phosphoglycerides ratio	KLF14 COBLL1 SIK3 HERPUD1	1.19e-03	68	200	4	EFO_0022327
Disease	free cholesterol in large VLDL measurement	KLF14 COBLL1 SIK3 HERPUD1	1.19e-03	68	200	4	EFO_0022265
Disease	Ovarian Mucinous Adenocarcinoma	SPEG TRRAP AATK	1.20e-03	31	200	3	C1335167
Disease	glucose measurement	CEBPB AFAP1L2 EHMT2 ZC3H4 KCNQ1 BSN COBLL1 FBRSL1 MYBPC3	1.21e-03	380	200	9	EFO_0004468
Disease	sphingomyelin 16:1 measurement	RALGDS NKX1-1	1.25e-03	8	200	2	EFO_0010392
Disease	Lymphoid leukemia	KMT2A LYL1	1.25e-03	8	200	2	C0023448
Disease	congenital heart disease (implicated_via_orthology)	USP42 KMT2A CHD6 MYBPC3	1.26e-03	69	200	4	DOID:1682 (implicated_via_orthology)
Disease	response to ketamine	ADD2 CHCHD2P9 KIAA1671 PDZD2	1.26e-03	69	200	4	EFO_0009748
Disease	sleep duration, high density lipoprotein cholesterol measurement	KLF14 CARMIL2 COBLL1 MACF1 HERPUD1	1.43e-03	121	200	5	EFO_0004612, EFO_0005271
Disease	triglycerides to total lipids in small HDL percentage	KLF14 COBLL1 SIK3 HERPUD1	1.47e-03	72	200	4	EFO_0022336
Disease	chymotrypsin-like elastase family member 2A measurement	RALGDS CBFA2T3	1.59e-03	9	200	2	EFO_0802399
Disease	Liver Diseases, Parasitic	RNF43 GNAS	1.59e-03	9	200	2	C0023897
Disease	Ehlers-Danlos syndrome (is_implicated_in)	COL5A1 TNXB	1.59e-03	9	200	2	DOID:13359 (is_implicated_in)
Disease	body fat percentage	ATXN2L KLF14 ZZEF1 ZC3H4 EIF4E3 TAL1 COBLL1 MIB2 KLF13 MACF1	1.93e-03	488	200	10	EFO_0007800
Disease	vital capacity	ATXN2L ZZEF1 CASZ1 SVEP1 EIF4E3 TBX4 TENT4B JPH2 GRIN2A TEAD1 SKI HVCN1 KCNH3 NCOR1 LTBP2 ZNF853 TNXB PDZD2	1.97e-03	1236	200	18	EFO_0004312
Disease	fish oil supplement exposure measurement, triglyceride measurement	MAP1A SIK3	1.98e-03	10	200	2	EFO_0004530, EFO_0600007
Disease	Pseudohypoaldosteronism, Type I	WNK1 GNAS	1.98e-03	10	200	2	C0268436
Disease	Pseudohypoaldosteronism	WNK1 GNAS	1.98e-03	10	200	2	C0033805
Disease	Hyperpotassemia and Hypertension, Familial	WNK1 GNAS	1.98e-03	10	200	2	C2713447
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	WNK1 GNAS	1.98e-03	10	200	2	C1449843
Disease	Pseudohypoaldosteronism, Type II	WNK1 GNAS	1.98e-03	10	200	2	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	WNK1 GNAS	1.98e-03	10	200	2	C1449842
Disease	apolipoprotein B measurement	PSD KLF14 RRBP1 CASZ1 AP1G1 MYBPHL KIF13B COBLL1 PRR30 PBX4 SIK3 HERPUD1	2.00e-03	663	200	12	EFO_0004615
Disease	cholesteryl esters to total lipids in medium LDL percentage	COBLL1 SIK3 HERPUD1	2.01e-03	37	200	3	EFO_0022252
Disease	apolipoprotein A 1 measurement	MAP1A KLF14 RRBP1 LACTB ZC3H4 KMT2A EIF4E3 COBLL1 FBRSL1 SIK3 GTPBP1 MACF1 HERPUD1 MYBPC3	2.03e-03	848	200	14	EFO_0004614
Disease	cholesterol in large HDL measurement	KLF14 COBLL1 SIK3 HERPUD1	2.17e-03	80	200	4	EFO_0021900
Disease	level of Ceramide (d40:1) in blood serum	PBX4 SIK3	2.42e-03	11	200	2	OBA_2045185
Disease	metabolic syndrome	KLF14 ZC3H4 KMT2A COBLL1 SIK3 HERPUD1	2.50e-03	200	200	6	EFO_0000195
Disease	lung adenocarcinoma (is_marker_for)	BHLHE41 FOXA1 EHMT2 FUBP1	2.70e-03	85	200	4	DOID:3910 (is_marker_for)
Disease	Carcinoma, Transitional Cell	KMT2A CHD6 NCOR1	2.71e-03	41	200	3	C0007138
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	KLF14 POLR2M RRBP1 COBLL1 PBX4 SIK3 HERPUD1	2.76e-03	274	200	7	EFO_0004530, EFO_0004612
Disease	smoking behavior, BMI-adjusted waist-hip ratio	JUND EHMT2 COBLL1 KLF13	2.82e-03	86	200	4	EFO_0004318, EFO_0007788
Disease	sialate O-acetylesterase measurement	BTBD2 GOLGA8B	2.89e-03	12	200	2	EFO_0803073
Disease	cholesteryl esters to total lipids in small LDL percentage	COBLL1 SIK3 HERPUD1	2.90e-03	42	200	3	EFO_0022255
Disease	revision of total hip arthroplasty, aseptic loosening	VCX3B BASP1 VCX2	2.90e-03	42	200	3	EFO_0010725, EFO_0020973
Disease	creatinine measurement	ANKRD9 SPEG CASZ1 LACTB KCNQ1 MYBPHL TAF4 GNAS BSN TBX4 PBX4 SCLY TBC1D10B IGSF21 SHISA8	3.36e-03	995	200	15	EFO_0004518
Disease	ovary epithelial cancer (is_marker_for)	FUBP1 PLK1	3.39e-03	13	200	2	DOID:2152 (is_marker_for)
Disease	Calcium channel blocker use measurement	KLF14 AHDC1 CASZ1 SVEP1 GNAS JPH2	3.41e-03	213	200	6	EFO_0009930
Disease	cystic fibrosis associated meconium ileus	CEBPB SLC26A9	3.94e-03	14	200	2	EFO_0004608
Disease	Left ventricular noncompaction	MIB2 MYBPC3	3.94e-03	14	200	2	C1960469
Disease	monocyte count	CEBPB ARID4B TSPOAP1 WNK1 AHDC1 SHC3 CIC CASZ1 JUND PKD1 EIF4E3 ZSCAN5A PBX4 FRAT2 GPR156 LYL1 MARCKS MYBPC3	3.94e-03	1320	200	18	EFO_0005091
Disease	serum gamma-glutamyl transferase measurement	MAP1A ANKRD9 SYNJ2 PKD1 TBC1D12 KMT2A TAF4 TAL1 BAHCC1 NEDD4L COBLL1 SKI FRAT2 IGSF21	3.97e-03	914	200	14	EFO_0004532
Disease	Neuroblastoma	MYCN CHD6 GNAS	3.99e-03	47	200	3	C0027819
Disease	Cardiomyopathy	BAG3 JPH2 MYBPC3	3.99e-03	47	200	3	cv:C0878544
Disease	cardiovascular disease	KLF14 RNF43 CASZ1 SVEP1 SCAF1 BAHCC1 FBRSL1 JPH2 MYBPC3	4.16e-03	457	200	9	EFO_0000319
Disease	developmental disorder of mental health (implicated_via_orthology)	GRIN2A RING1 NCOR1	4.49e-03	49	200	3	DOID:0060037 (implicated_via_orthology)
Disease	BMI-adjusted leptin measurement	KLF14 COBLL1	4.53e-03	15	200	2	EFO_0007793
Disease	pancreas fat measurement	CEBPB CBFA2T3	4.53e-03	15	200	2	EFO_0600049
Disease	body surface area	WNK1 ZC3H4 GNAS TBX4 PBX4 TEAD1 ARHGEF40 AATK GPR156 MACF1 LTBP2	4.64e-03	643	200	11	EFO_0022196
Disease	phospholipids:total lipids ratio	PSD COBLL1 SIK3 MACF1 HERPUD1 MYBPC3	4.65e-03	227	200	6	EFO_0020946
Disease	triglyceride measurement, alcohol drinking	KLF14 COBLL1 HERPUD1 MYBPC3	4.67e-03	99	200	4	EFO_0004329, EFO_0004530
Disease	polyunsaturated fatty acids to total fatty acids percentage	COBLL1 SIK3 HERPUD1	4.76e-03	50	200	3	EFO_0022303
Disease	cholesteryl esters to total lipids in IDL percentage	COBLL1 SIK3 MACF1	4.76e-03	50	200	3	EFO_0022247
Disease	obsolete_red blood cell distribution width	WNK1 IER5L TMEM259 ZC3H4 TBC1D12 STK39 TAL1 RALGDS CARMIL2 FBRSL1 PBX4 SIK3 CBFA2T3 SKI TRIM33 KLF1 KLF13 CBX6	4.85e-03	1347	200	18	EFO_0005192
Disease	triglyceride measurement, alcohol consumption measurement	KLF14 COBLL1 HERPUD1 MYBPC3	5.01e-03	101	200	4	EFO_0004530, EFO_0007878
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	COBLL1 SIK3 HERPUD1	5.03e-03	51	200	3	EFO_0022302
Disease	cholesterol to total lipids in small HDL percentage	COBLL1 SIK3 HERPUD1	5.03e-03	51	200	3	EFO_0022240
Disease	alcohol consumption measurement, high density lipoprotein cholesterol measurement	KLF14 LACTB COBLL1 HERPUD1 MYBPC3	5.04e-03	162	200	5	EFO_0004612, EFO_0007878
Disease	infantile hypertrophic pyloric stenosis	BARX1 SIK3	5.15e-03	16	200	2	EFO_0004707
Disease	Chromosome Aberrations	MYCN KMT2A	5.15e-03	16	200	2	C0008625
Disease	Autosome Abnormalities	MYCN KMT2A	5.15e-03	16	200	2	C0004403
Disease	leptin measurement, type 2 diabetes mellitus	KLF14 COBLL1	5.15e-03	16	200	2	EFO_0005000, MONDO_0005148
Disease	succinylcarnitine measurement	LACTB IER5L	5.15e-03	16	200	2	EFO_0020020
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	LACTB COBLL1 SIK3 MACF1	5.37e-03	103	200	4	EFO_0008595, EFO_0020944
Disease	Retinitis Pigmentosa	AIPL1 CNGB1 UNC119 CROCC	5.56e-03	104	200	4	C0035334
Disease	Familial thoracic aortic aneurysm and aortic dissection	PKD1 COL5A1 SKI	5.60e-03	53	200	3	C4707243
Disease	triglycerides in HDL measurement	COBLL1 SIK3 HERPUD1	5.60e-03	53	200	3	EFO_0022317
Disease	free cholesterol to total lipids in small LDL percentage	COBLL1 SIK3 HERPUD1	5.60e-03	53	200	3	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	COBLL1 SIK3 HERPUD1	5.60e-03	53	200	3	EFO_0022258
Disease	reticulocyte measurement	ANKRD9 KLF14 WIZ USP42 ZC3H4 UBAC1 KCNQ1 BSN COBLL1 CBFA2T3 SKI UBE2O KLF1 KLF13 PDZD2	5.63e-03	1053	200	15	EFO_0010700
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	KLF14 JUND COBLL1 KLF13	5.75e-03	105	200	4	EFO_0007788, EFO_0008007, EFO_0008343
Disease	body fat percentage, type 2 diabetes mellitus	KLF14 COBLL1	5.81e-03	17	200	2	EFO_0007800, MONDO_0005148
Disease	lysophosphatidylcholine 18:1 measurement	CCDC85A TAF4	5.81e-03	17	200	2	EFO_0010360
Disease	sex interaction measurement, ulcerative colitis	EHMT2 TNXB	5.81e-03	17	200	2	EFO_0000729, EFO_0008343
Disease	alpha-L-iduronidase measurement	TMEM271 NKX1-1	5.81e-03	17	200	2	EFO_0020139
Disease	alcohol drinking, high density lipoprotein cholesterol measurement	KLF14 LACTB COBLL1 HERPUD1 MYBPC3	5.87e-03	168	200	5	EFO_0004329, EFO_0004612

Protein segments in the cluster

Peptide	Gene	Start	Entry
VPLPAAEQGPAGASA	TBC1D12	296	O60347
AAASPPHPAPEEGVA	ARID4B	951	Q4LE39
AAPAPGSAALLEPPE	FBRSL1	911	Q9HCM7
AKEAAGPPEPGPAFS	BAHCC1	321	Q9P281
PSQDAPRDPAGEPAG	AMER2	251	Q8N7J2
AASGPSESPSPPAAE	EIF3B	76	P55884
PAEPPTAPSAELSAG	AIPL1	351	Q9NZN9
TAPSAELSAGPPAEP	AIPL1	356	Q9NZN9
PESPPGAEAVPEAAV	ARHGEF40	316	Q8TER5
EVTAAAGPAPPTAPE	CBX6	331	O95503
PTAPEPAGASSEPEA	CBX6	341	O95503
PFAGPREPGNPESSA	BHLHE41	456	Q9C0J9
DSAPVAAASVPAPPA	CASZ1	846	Q86V15
PPDAAAPGPREGAAA	CASZ1	1651	Q86V15
EPQAGPSARGSPSPA	CARMIL2	981	Q6F5E8
PAVGAPPPGDEASSV	GTPBP1	611	O00178
SPPASAGSAEEPAAP	AJM1	631	C9J069
PSCPDAVVATPPGAS	AFAP1L2	626	Q8N4X5
AAAGSEPPPATTSPE	EHMT2	161	Q96KQ7
PAAAVPEGTAAEGAP	DUS3L	241	Q96G46
PGATAAATGLPPEPE	AHDC1	216	Q5TGY3
VAQPPAAAPPSAVGS	CHCHD2	31	Q9Y6H1
PTVPAAAATCEPPSG	CDK5R2	126	Q13319
DDVIGQAPAEASPPP	COBLL1	936	Q53SF7
EAAEAPVPATPTGAA	ARMCX2	216	Q7L311
PPAAASPCLGPVAAA	ATXN2L	51	Q8WWM7
APPNGSAAEPPTEAA	PALM	341	O75781
APAPGAPGEATPQED	TSPOAP1	306	O95153
AATGDPPAAPRPAFV	RGS3	841	P49796
AAAHNPADEPGPGAP	GOLGA8S	541	H3BPF8
EPSPGAPAPQELGAA	GOLGA8F;	351	Q08AF8
ASGAFVPPPSAQEIP	HERPUD1	191	Q15011
APAGESPQPKAAPEA	NIBAN2	676	Q96TA1
EQGPTVSPAPADEPS	KCNH3	736	Q9ULD8
GDINLTGAPAAAPAP	AP1G1	661	O43747
TGAPAAAPAPASVPQ	AP1G1	666	O43747
SPHPSAAVPAADPAD	TENT4B	56	Q8NDF8
EPPGPVKAEPAHTAA	MAPK7	16	Q13164
APDSPASPASDGPAL	JPH2	176	Q9BR39
SPAAPAAPPVASDLG	KCNQ1	66	P51787
GPPSSASPEVEAGPQ	MAP1A	2421	P78559
SVLDSPAEGPGPAAP	MAPK8IP3	1256	Q9UPT6
PAEGPGPAAPASEVE	MAPK8IP3	1261	Q9UPT6
ATPASPSAAPEPEKG	KIAA1671	461	Q9BY89
AVAVTAAPGPKPAAP	NFS1	11	Q9Y697
APPDPAKAGTDPNSA	FUBP1	521	Q96AE4
EGRAAAPDVAPAPGP	HVCN1	66	Q96D96
RGAAPAQSPAAPDPE	LACTB	61	P83111
PGPAAAAAPAAGREP	GPR137C	6	Q8N3F9
SAPPGELAPAAAAPE	JUND	176	P17535
EASGPPAAAPPALIE	JPH4	261	Q96JJ6
SVPGPAQAAAPPEVG	BSN	286	Q9UPA5
PAAIKEAAGAPAPAP	BSN	2316	Q9UPA5
TEPPGPKGAAPAAAA	BARX1	36	Q9HBU1
GPAASAEEPKPVEAP	BASP1	201	P80723
GAQEVPGPAAALAPS	PNRC1	136	Q12796
PGPAAALAPSPAAAA	PNRC1	141	Q12796
HEGSPSPGEKAAAPP	PDZD2	1286	O15018
AEPSPSSEPEAGPSQ	FAM214B	6	Q7L5A3
NAPDAIPESGVEPPA	GPS1	111	Q13098
GADPGEAPTPPSSAQ	GPR153	531	Q6NV75
GPEAGAPPTLAPAVA	MEX3D	106	Q86XN8
AAAVPTPEEPASPAA	MACF1	1121	O94854
PSAPGEAPAAASTQP	TUBGCP6	931	Q96RT7
AVVADPVPGPPEAAH	CBFA2T3	601	O75081
PAGGPAPSTAAAPAE	RPLP1	76	P05386
PQGAPPFLEEAPSAS	INSM2	31	Q96T92
AAAESPPVEPGPGSL	CRACDL	516	Q6NV74
PPGSRAAAAAAAPEP	EIF4E3	16	Q8N5X7
AEPAAGAPVAAEPAA	PRR27	146	Q6MZM9
GAPVAAEPAAEAPVG	PRR27	151	Q6MZM9
EGAPAPGPAASPQTL	FOXA1	321	P55317
GATPQPATASPAGDP	PBX4	351	Q9BYU1
EKPASPSAAVPPGTD	ARHGAP29	1181	Q52LW3
LPAAPAPTSGQAEPG	BECN2	26	A8MW95
VAQPPAAAPPSAVGS	CHCHD2P9	31	Q5T1J5
PAAPASPAAVPSEGS	CENPB	151	P07199
PVPGSPARDAPAEGS	CROCC	1456	Q5TZA2
AQKESPGAPPAFASP	FBRS	206	Q9HAH7
DAVPLSEPPAASSGP	IGSF21	191	Q96ID5
AAAHNPADEPGPGAP	GOLGA8K	546	D6RF30
EPSPGAPAPQELGAA	GOLGA8DP	351	Q0D2H9
DAFVGPALAPAPAPE	KLF1	146	Q13351
PPSADPALVAGPAEE	POLR2M	11	Q6EEV4
GPGPATSAPEPATAA	CHD6	2331	Q8TD26
EAAAAALPAAVPGPG	SLC49A4	31	Q96SL1
APPAPNAPAAGEDTT	GAS2L1	171	Q99501
PLGAPQAPAPATATD	CEBPB	81	P17676
PAPGAAVLSSEPAEP	CENPT	421	Q96BT3
ESDGSPVPSSQPAFP	DUSP7	231	Q16829
PSAAGAPASAPGEPR	ANKRD9	211	Q96BM1
SSNPAPPPGEGADDL	COL5A1	386	P20908
APAGSSAAPPAPVED	CCDC85A	21	Q96PX6
APSAAGPGAPPEQEA	MARCKS	281	P29966
GPEDTVPEPAFPNTA	LTBP2	1681	Q14767
APTPAPGSELEVAPA	RALGDS	296	Q12967
SPADAEPPQASPGQG	MYBPHL	21	A2RUH7
AARSQPAPPADPDGS	LYL1	246	P12980
SGAPATAPDSAGQPP	TMEM259	486	Q4ZIN3
VPTGSPSPDLAPAAE	FMNL1	521	O95466
PEGAAPPASSPNKDV	GPR156	396	Q8NFN8
PAPEPTSPGAEGAAA	KLF13	101	Q9Y2Y9
TSPGAEGAAAAPPSP	KLF13	106	Q9Y2Y9
SEVGAAPPESALPGP	KLF14	41	Q8TD94
ASENPGDGPVAQPSP	KMT2A	2561	Q03164
PETSHPSQGPAEAPA	KNDC1	396	Q76NI1
EGASSAAPGSPVPAP	KNDC1	771	Q76NI1
ESAAPAAAPTAEAPP	DDX17	36	Q92841
NSADEPGPGAPAPQE	GOLGA8R	551	I6L899
AARNPAAEPSPGAPA	GOLGA8B	511	A8MQT2
AAEPSPGAPAPQELG	GOLGA8B	516	A8MQT2
AAAAAAAAAPGPTPP	BTBD2	46	Q9BX70
APAEATPPKPGEAEA	BAG3	401	O95817
PQAPQDGPPGAEEAA	DHX34	1091	Q14147
RGAPAAAAAAAPPPT	SAMD1	116	Q6SPF0
AAAAAATAPPSPGPA	SAMD1	151	Q6SPF0
PASDPDAPPTAGQGR	PRR18	191	Q8N4B5
APRPAAGAGAAAEAP	CRLS1	76	Q9UJA2
AACSAPPGAAPPAAA	IER5L	206	Q5T953
VSSDSAPDSAPGPAP	RING1	186	Q06587
DPGDPGAAPASVPTA	IRGQ	246	Q8WZA9
PPASAETVGPAPSGA	FRAT2	96	O75474
PSPPSGPETAEAAAL	MLNR	216	O43193
VSPDVPPPSAGSDAS	PKD1	4171	P98161
PAPAAGEEGPAPLSE	PCGF6	36	Q9BYE7
PDGSEVASAAPAPGP	MIB2	876	Q96AX9
TPGRAPAADAAPAGP	RPH3AL	296	Q9UNE2
EPSPGAPAPQELGAA	GOLGA8A	546	A7E2F4
PEAQDGPPSPLSEAS	KIF13B	1551	Q9NQT8
LEPPPHASGVPEANS	ARHGAP20	1071	Q9P2F6
APAAQVSVPAPSGEP	RUSC2	736	Q8N2Y8
PAAAAVAAGPEPAPA	TAF4	141	O00268
AGAAPVPAAAPDAGA	TAF5	76	Q15542
SQDVPPPATAAAGGP	SYN1	641	P17600
DEDAAGSPAEPSPPA	STK11IP	976	Q8N1F8
GSPAEPSPPAASGEA	STK11IP	981	Q8N1F8
PSPPAASGEASEKVP	STK11IP	986	Q8N1F8
ESAAAAPQGGPELPP	PWWP2A	101	Q96N64
AAGPAAQEAEPPLTA	TRIM33	26	Q9UPN9
AVTAPEAESGPAAPG	VCX3A	61	Q9NNX9
EAESGPAAPGPSDQP	VCX3A	66	Q9NNX9
AVTAPEAESGPAAPG	VCX3B	61	Q9H321
EAESGPAAPGPSDQP	VCX3B	66	Q9H321
AVTAPEAESGPAAPG	VCY	61	O14598
EAESGPAAPGPSDQP	VCY	66	O14598
EAAPASAASAPGPAP	TAF10	11	Q12962
VPFLPGTSPSADGPD	PSD	386	A5PKW4
PPPGVGAQAAAAAEE	TBC1D25	16	Q3MII6
PASDEAPPGAGASVP	SYNJ2	1306	O15056
QSEPPASAEAPGEPS	SLC26A9	636	Q7LBE3
FVDPNRSPAGPAATP	TCOF1	961	Q13428
GAPLPSEEASAPDAP	AATK	806	Q6ZMQ8
GAPPLAASDTVPAAP	NKX1-1	51	Q15270
PAASAGASLEPPAAP	OGA	21	O60502
GASLEPPAAPAPGED	OGA	26	O60502
PAPAPASVTAELPGD	TAL1	101	P17542
PAAPADPDSGATPED	GNAS	396	Q5JWF2
AAPADPDSGAAPDAP	GNAS	436	Q5JWF2
PDSGAAPDAPADPDS	GNAS	441	Q5JWF2
APDAPADPDSGAAPD	GNAS	446	Q5JWF2
ADPDSGAAPDAPADP	GNAS	451	Q5JWF2
APADPDAGAAPEAPA	GNAS	461	Q5JWF2
HVAPAAPDAGAPTAP	GNAS	486	Q5JWF2
EGPESATPAPGALDP	PRR36	1201	Q9H6K5
GDSQPAAAAPHPEPS	GPR182	366	O15218
ASAAAAAATEEPPPP	NCOR1	596	O75376
PVAALGATAEPPESP	FGD1	941	P98174
EPAPGPVDASSICPS	RNF43	621	Q68DV7
AAPDGSAPSAPRAPA	SHC3	106	Q92529
APGSPAAPAAVSPAA	SIK3	31	Q9Y2K2
AAPAAVSPAAGQPRP	SIK3	36	Q9Y2K2
PEAQGPAAPGTTAPE	SHISA8	41	B8ZZ34
APALAEDGPPTVAPG	WIZ	1291	O95785
PDPAATHDGPQSPGA	PKN1	101	Q16512
IPAPPAPGDEAAGSR	SVEP1	46	Q4LDE5
PLASGPEGPDVAVAA	DZIP1	21	Q86YF9
GAAAVPAPVPAATEP	SKI	56	P12755
PDARPGAVQASSPAP	SUPT20HL2	621	P0C7V6
APEEPGSPAKSAPAS	ADD2	586	P35612
ELAPAPSAFPGPVSA	ANHX	326	E9PGG2
AATPTEQPPGAEAPL	CIC	1521	Q96RK0
APDTASAAPPVVPGL	CHRD	671	Q9H2X0
VATGAASDPAPPGRP	CNGB1	186	Q14028
ASARDPAPAPAPVAG	C15orf39	736	Q6ZRI6
VSGAAALVPAPSGPD	PRXL2C	11	Q7RTV5
PSGPDSGQPLAAAVA	PRXL2C	21	Q7RTV5
AASNTGTPDGPEAPP	PITPNM1	281	O00562
APGRDAPAPAASQPS	SCLY	6	Q96I15
SALAEAPEGLSPAPP	USP42	846	Q9H9J4
PPLPPAVVTGAEAAA	TEX13D	241	A0A0J9YY54
APAKETEPTPASGPA	ZNF324	531	O75467
KEVPGEAPAPSADPA	ZNF771	46	Q7L3S4
APIPQPPAESESGSE	UNC119	26	Q13432
QGSPPEASLPPSAGD	ZFHX2	546	Q9C0A1
AAEGPNLTPEASPDP	ZFHX2	1086	Q9C0A1
AGAPASSPEAPPAEQ	RRBP1	1271	Q9P2E9
AVTAPEAESAPAAPG	VCX2	61	Q9H322
EAESAPAAPGPSDQP	VCX2	66	Q9H322
PAAPASAPAAGPAVA	MYCN	206	P04198
GPASAQPLPAPEAAH	TFE3	221	P19532
ALPSPGQEPAAGASP	SPEG	1991	Q15772
PAPAPVADGDIPSQF	SAMD4B	461	Q5PRF9
VDLGEPAPAPPAADS	SCAF1	461	Q9H7N4
VTLAPAADDAGEPPP	SPIRE1	96	Q08AE8
GAPAPPAVEAPAVGI	PRX	276	Q9BXM0
TPTPSEQDADPGPAS	ZSCAN1	16	Q8NBB4
APGAPPLQAETPGSA	TNXB	3881	P22105
APVPAPAPASDSASG	UBE2O	31	Q9C0C9
PGPASPVSHPDGQEA	ZSCAN5A	336	Q9BUG6
PSGPESPEPAAVAGV	TBC1D10B	106	Q4KMP7
EPAPNAPGDIAAAFP	TACC2	141	O95359
QAPAPGEATAAPAPL	TBX6	326	O95947
AVTAPEAESAPAAPG	VCX	61	Q9H320
EAESAPAAPGPSDQP	VCX	66	Q9H320
PPAAAPQAGEDPTET	SOCS7	96	O14512
AAAPAATTATPPPEG	ZC3H4	1226	Q9UPT8
AVAAPAVVAIPGPAG	ZNF853	451	P0CG23
VFPSPEEAPSAASPG	VWA5B2	586	Q8N398
AFPAAVAPPAGRPET	ZNF316	331	A6NFI3
SGSAPAPAPKPEAAA	ZNF316	946	A6NFI3
TEAPPGDALADPPSG	ZSCAN18	306	Q8TBC5
PTEAAPPATGDQSPG	ZZEF1	1476	O43149
SPPGPGADVVAAAAA	TBX4	46	P57082
LPGQAPPEAEGATAA	UBAC1	241	Q9BSL1
FDPVPPAGNSSPTEA	ZNF142	981	P52746
LDPVPPAGNSSPTEA	ZNF142	1001	P52746
EPAQPAPGSPAETTE	ZNF142	1311	P52746
VTAPIPGFEPASAPA	TEAD1	186	P28347
EATPQAGPPPIAAAA	VPS9D1	551	Q9Y2B5
AGPPPIAAAAIGADD	VPS9D1	556	Q9Y2B5
AAPGEQAVAGPAPST	WNK1	141	Q9H4A3
PPVTALPQDGAAPAT	WNK2	1426	Q9Y3S1
GAEPPAPEPSAGASS	PIGG	41	Q5H8A4
PAAQARADPVPGTPS	PRR30	341	Q53SZ7
AEDGAEAQAPSPPPA	GTF3C1	1901	Q12789
GDPGAPAVVPAPVSA	nan	41	Q6ZS46
AAPAPAPAPAAQAVG	STK39	41	Q9UEW8
GEEAAAAAPAPGTPA	UBR4	6	Q5T4S7
AAPSPEDPAGTPAVD	PRR23C	41	Q6ZRP0
PAAPAGAPEATPGES	TMEM271	91	A0A286YF58
ASGSPAPQSEGAPPR	WWC2-AS2	161	Q96NR7
EAALPGVPTAPAAPG	TRRAP	481	Q9Y4A5
AAPGAPAAAPPAKEI	PLK1	26	P53350
PVAPEAPGTSPAGAA	KLHL35	86	Q6PF15
GSAAASVPLDPEFPP	NACC2	471	Q96BF6
PAPAPAEATGAPGEA	MYBPC3	106	Q14896
AEATGAPGEAPAPAA	MYBPC3	111	Q14896
PAPAAELGESAPSPK	MYBPC3	121	Q14896
PAPSAAAEKGPPALN	GRIN2A	21	Q12879
AVAEQGHLPPPSAPA	NEDD4L	346	Q96PU5